| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.61e-08 | 11 | 165 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.28e-07 | 130 | 165 | 10 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.20e-07 | 32 | 165 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM2 TPM3 RALA CENPE TRPM7 PACSIN1 MYO9B SYNE1 SPTBN1 ACTB OBSCN PSTPIP1 ADD1 ADD3 MYO5C TWF1 TTLL12 PPARGC1A ARHGEF10 DNM3 UXT DNM1 UTRN EPB41L2 PICK1 MX1 DNM2 | 3.47e-07 | 1099 | 165 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | TPM2 TPM3 MYO9B SYNE1 SPTBN1 PSTPIP1 ADD1 ADD3 MYO5C TWF1 UXT PICK1 | 4.26e-07 | 227 | 165 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.19e-06 | 42 | 165 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | protein kinase binding | CENPE DSP POTEF RPS6 ACTB SREBF1 ACTG1 E2F1 SRCIN1 PDPK2P ADD3 POTEE DNM3 PRKAR2A POTEI DNM1 UTRN CDH5 TOP2A PICK1 DNM2 SFN | 3.19e-06 | 873 | 165 | 22 | GO:0019901 |
| GeneOntologyMolecularFunction | actin binding | TPM2 TPM3 TRPM7 MYO9B SYNE1 SPTBN1 PSTPIP1 ADD1 ADD3 MYO5C TWF1 UXT UTRN EPB41L2 PICK1 | 1.09e-05 | 479 | 165 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | kinase binding | CENPE DSP POTEF RPS6 ACTB SREBF1 ACTG1 E2F1 SRCIN1 PDPK2P ADD3 POTEE DNM3 PRKAR2A POTEI DNM1 UTRN CDH5 TOP2A PICK1 DNM2 SFN | 1.65e-05 | 969 | 165 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RALA RALB MYO9B ACTB GIMAP7 RUVBL2 ENTPD4 ARHGAP5 DNM3 ABCB11 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 2.31e-05 | 775 | 165 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.93e-05 | 22 | 165 | 4 | GO:0050998 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RALA RALB MYO9B ACTB GIMAP7 RUVBL2 ENTPD4 ARHGAP5 DNM3 ABCB11 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 6.72e-05 | 839 | 165 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RALA RALB MYO9B ACTB GIMAP7 RUVBL2 ENTPD4 ARHGAP5 DNM3 ABCB11 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 6.83e-05 | 840 | 165 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RALA RALB MYO9B ACTB GIMAP7 RUVBL2 ENTPD4 ARHGAP5 DNM3 ABCB11 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 6.83e-05 | 840 | 165 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | structural molecule activity | TPM2 RELN NUP85 DSP POTEF RPS6 SPTBN1 ACTB OBSCN ACTG1 EVPL ADD1 ADD3 POTEE PXDN MRPL14 DNM3 POTEI EPB41L2 | 1.47e-04 | 891 | 165 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | ATP-dependent activity | SLC27A6 CENPE MYO9B ACTB RUVBL2 MYO5C BPTF AACS ABCB11 ASCC3 ABCD2 DDX24 TOP2A MOV10 DNAH11 | 1.81e-04 | 614 | 165 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | membrane curvature sensor activity | 2.03e-04 | 3 | 165 | 2 | GO:0140090 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DSP SPTBN1 OBSCN EVPL ARFIP2 ADD1 TWF1 KIRREL3 TENM4 TENM3 PRKCA UTRN CDH5 SFN | 4.65e-04 | 599 | 165 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | GTPase activity | 5.58e-04 | 341 | 165 | 10 | GO:0003924 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 9.87e-04 | 24 | 165 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.36e-03 | 199 | 165 | 7 | GO:1901981 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 1.39e-03 | 7 | 165 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | ATPase binding | 2.04e-03 | 108 | 165 | 5 | GO:0051117 | |
| GeneOntologyMolecularFunction | phospholipid binding | RASA2 PACSIN1 SPTBN1 VEPH1 OBSCN VPS36 ARFIP2 TWF1 SNX7 DNM1 PICK1 DNM2 | 2.05e-03 | 548 | 165 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.18e-03 | 66 | 165 | 4 | GO:0005080 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM2 TPM3 RALA TRPM7 DSP PACSIN1 MYO9B POTEF SPTBN1 ACTB OBSCN ACTG1 ARHGEF18 SRCIN1 PSTPIP1 ARFIP2 ADD1 ADD3 MYO5C TWF1 POTEE KANK1 ARHGEF10 PCDH15 POTEI EPB41L2 PICK1 DNM2 | 1.15e-09 | 912 | 167 | 28 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TPM2 TPM3 RALA TRPM7 PACSIN1 POTEF SPTBN1 ACTB OBSCN ACTG1 ARHGEF18 SRCIN1 PSTPIP1 ARFIP2 ADD1 ADD3 MYO5C TWF1 POTEE KANK1 ARHGEF10 PCDH15 POTEI EPB41L2 PICK1 DNM2 | 1.61e-09 | 803 | 167 | 26 | GO:0030036 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.60e-07 | 31 | 167 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | CENPE SPTBN1 BAZ1B ARHGEF18 GDI2 ADD1 ADD3 TWF1 LIF PPARGC1A KANK1 CDH5 TOP2A PICK1 WDR44 DNM2 | 3.42e-07 | 421 | 167 | 16 | GO:0010639 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.44e-07 | 35 | 167 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM2 TPM3 NAT8B DSP PACSIN1 USP9X SPTBN1 OBSCN ACTG1 ARHGEF18 EXT1 PSTPIP1 ARFIP2 ADD1 ADD3 MYO5C TWF1 KANK1 PXDN ARHGEF10 PCDH15 CDH5 PICK1 DNM2 | 8.35e-07 | 957 | 167 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament organization | TPM2 TPM3 PACSIN1 SPTBN1 ACTG1 ARHGEF18 PSTPIP1 ARFIP2 ADD1 ADD3 MYO5C TWF1 KANK1 ARHGEF10 PCDH15 PICK1 DNM2 | 8.75e-07 | 509 | 167 | 17 | GO:0007015 |
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN PACSIN1 MYO9B USP9X POTEF SYNE1 ACTB ACTG1 ARHGEF18 EXT1 SRCIN1 GRHL2 ADD1 POTEE LIF KIRREL3 KANK1 PCDH15 LRP2 DNM3 PRKCA POTEI CDH5 EPB41L2 MOV10 DNM2 BRWD1 | 1.19e-06 | 1194 | 167 | 27 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 1.23e-06 | 24 | 167 | 5 | GO:0150105 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | RALA RALB CENPE SYNE1 SPTBN1 ACTB SREBF1 BAZ1B ACTG1 ARHGEF18 DAZL ARFIP2 RUVBL2 GDI2 ADD1 ADD3 TWF1 LIF PPARGC1A KANK1 ARHGEF10 SNX7 UCHL5 CDH5 TOP2A PICK1 WDR44 DNM2 | 3.50e-06 | 1342 | 167 | 28 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB2 FILIP1 RELN DSP USP9X POTEF RPS6 ACTB ACTG1 EXT1 SRCIN1 PDPK2P GRHL2 ADD1 POTEE KIRREL3 TENM4 TENM3 DNM3 PRKCA POTEI CDH5 PICK1 | 3.97e-06 | 974 | 167 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | CENPE PACSIN1 RPS6 SPTBN1 BAZ1B ARHGEF18 GDI2 ADD1 ADD3 TWF1 LIF TGFBR3 PPARGC1A KANK1 DGUOK DNM3 CDH5 TOP2A PICK1 WDR44 DNM2 | 7.00e-06 | 864 | 167 | 21 | GO:0051129 |
| GeneOntologyBiologicalProcess | neuron development | GABRB2 RELN PACSIN1 USP9X POTEF SYNE1 ACTB ACTG1 PRPH2 EXT1 SRCIN1 TWF1 POTEE LIF KIRREL3 KANK1 TENM4 TENM3 DGUOK PCDH15 LRP2 DNM3 MTR PRKCA POTEI PICK1 MOV10 DNM2 | 1.75e-05 | 1463 | 167 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN PACSIN1 MYO9B USP9X POTEF SYNE1 ACTB ACTG1 EXT1 SRCIN1 POTEE KIRREL3 KANK1 LRP2 DNM3 PRKCA POTEI MOV10 DNM2 | 3.74e-05 | 819 | 167 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN PACSIN1 MYO9B USP9X POTEF SYNE1 ACTB ACTG1 EXT1 SRCIN1 POTEE KIRREL3 KANK1 LRP2 DNM3 PRKCA POTEI MOV10 DNM2 | 4.19e-05 | 826 | 167 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 4.23e-05 | 9 | 167 | 3 | GO:0003223 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 5.70e-05 | 51 | 167 | 5 | GO:0098884 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 5.70e-05 | 51 | 167 | 5 | GO:0140239 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | RALA PACSIN1 SYNE1 ACTB ACTG1 OTOF DNM3 PRKCA DNM1 PICK1 DNM2 | 6.39e-05 | 321 | 167 | 11 | GO:0099003 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 8.20e-05 | 11 | 167 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RALA RALB USP9X SYNE1 RPS6 SPTBN1 ACTG1 ARHGEF18 SRCIN1 GDI2 ADD1 ADD3 TWF1 TGFBR3 KANK1 ARHGEF10 SNX7 DNM3 PRKCA CDC34 CDH5 WDR44 DNM2 | 9.19e-05 | 1189 | 167 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 9.72e-05 | 91 | 167 | 6 | GO:0032272 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.06e-04 | 58 | 167 | 5 | GO:0099590 | |
| GeneOntologyBiologicalProcess | neuron projection development | RELN PACSIN1 USP9X POTEF SYNE1 ACTB ACTG1 EXT1 SRCIN1 TWF1 POTEE LIF KIRREL3 KANK1 TENM3 DGUOK PCDH15 LRP2 DNM3 MTR PRKCA POTEI MOV10 DNM2 | 1.10e-04 | 1285 | 167 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RALA CFAP91 NUP85 USP9X SYNE1 ODAD4 ARFIP2 GDI2 TWF1 KANK1 CEP83 PCDH15 DNM3 WDR44 DNM2 PCNT | 1.14e-04 | 670 | 167 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | receptor internalization | 1.21e-04 | 182 | 167 | 8 | GO:0031623 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RALA RALB RELN RASA2 MYO9B OBSCN ARHGEF18 ARFIP2 GDI2 ARHGAP5 KANK1 PLEKHG6 ARHGEF10 DNM2 | 1.28e-04 | 538 | 167 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.31e-04 | 96 | 167 | 6 | GO:0048488 | |
| GeneOntologyBiologicalProcess | synapse organization | GABRB2 FILIP1 RELN USP9X POTEF ACTB ACTG1 SRCIN1 POTEE KIRREL3 TENM4 TENM3 DNM3 PRKCA POTEI PICK1 | 1.46e-04 | 685 | 167 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell projection assembly | RALA CFAP91 NUP85 USP9X SYNE1 ODAD4 ARFIP2 GDI2 TWF1 KANK1 CEP83 PCDH15 DNM3 WDR44 DNM2 PCNT | 1.46e-04 | 685 | 167 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | lamellipodium organization | 1.55e-04 | 99 | 167 | 6 | GO:0097581 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | SPTBN1 ACTG1 ARHGEF18 ARFIP2 ADD1 ADD3 TWF1 KANK1 ARHGEF10 PICK1 | 1.73e-04 | 300 | 167 | 10 | GO:0110053 |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 1.83e-04 | 102 | 167 | 6 | GO:0140238 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.84e-04 | 246 | 167 | 9 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.88e-04 | 194 | 167 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | vesicle scission | 1.94e-04 | 3 | 167 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 2.08e-04 | 197 | 167 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 2.21e-04 | 15 | 167 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.43e-04 | 313 | 167 | 10 | GO:0099173 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | RALA DSP SPTBN1 ACTG1 ARHGEF18 ARFIP2 ADD1 ADD3 TWF1 KANK1 ARHGEF10 PICK1 | 2.45e-04 | 438 | 167 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 2.73e-04 | 39 | 167 | 4 | GO:0099149 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | RALA RALB RELN CENPE PACSIN1 SYNE1 DAZL RUVBL2 ADD1 ADD3 TWF1 LIF TENM3 ARHGEF10 SNX7 UCHL5 LRP2 DNM3 PRKCA DNM1 CDC34 CDH5 PICK1 DNM2 | 2.74e-04 | 1366 | 167 | 24 | GO:0051130 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN PACSIN1 USP9X POTEF SYNE1 ACTB ACTG1 EXT1 SRCIN1 POTEE KIRREL3 LRP2 DNM3 PRKCA POTEI MOV10 DNM2 | 2.85e-04 | 802 | 167 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 2.89e-04 | 111 | 167 | 6 | GO:0036465 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | RALA SPTBN1 ACTG1 ARHGEF18 ARFIP2 ADD1 ADD3 TWF1 KANK1 ARHGEF10 PICK1 | 3.05e-04 | 384 | 167 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of endocytosis | RALA PACSIN1 SYNE1 ACTB ACTG1 ADD1 LRP2 PRKCA DNM1 PICK1 DNM2 | 3.41e-04 | 389 | 167 | 11 | GO:0030100 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 3.58e-04 | 75 | 167 | 5 | GO:0030837 | |
| GeneOntologyBiologicalProcess | organelle assembly | RALB RELN CFAP91 CENPE USP9X SYNE1 RPS6 OBSCN ACTG1 ODAD4 VPS36 ARFIP2 GDI2 ARHGEF10 EIF2S1 SNX7 CEP83 PCDH15 WDR44 DNM2 PCNT | 3.58e-04 | 1138 | 167 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 3.87e-04 | 4 | 167 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | cytosolic ciliogenesis | 3.87e-04 | 4 | 167 | 2 | GO:0061824 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | RELN RASA2 MYO9B OBSCN ARHGEF18 ARHGAP5 KANK1 PLEKHG6 ARHGEF10 DNM2 | 3.97e-04 | 333 | 167 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 4.36e-04 | 337 | 167 | 10 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 4.37e-04 | 44 | 167 | 4 | GO:1903421 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma membrane bounded cell projection assembly | 4.77e-04 | 45 | 167 | 4 | GO:0120033 | |
| GeneOntologyBiologicalProcess | actin filament capping | 5.19e-04 | 46 | 167 | 4 | GO:0051693 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRB2 RELN USP9X RPS6 ACTB ACTG1 SRCIN1 PDPK2P GRHL2 KIRREL3 DNM3 PRKCA CDH5 | 7.62e-04 | 569 | 167 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | negative regulation of cilium assembly | 8.20e-04 | 23 | 167 | 3 | GO:1902018 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 8.29e-04 | 52 | 167 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | NAA15 CENPE USP9X CDKN2AIP SREBF1 USP25 RUVBL2 PPARGC1A IPO9 UXT | 8.59e-04 | 368 | 167 | 10 | GO:0031647 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTBN1 ACTG1 ARHGEF18 ARFIP2 ADD1 ADD3 TWF1 KANK1 ARHGEF10 CDH5 PICK1 | 9.10e-04 | 438 | 167 | 11 | GO:1902903 |
| GeneOntologyBiologicalProcess | protein localization to bicellular tight junction | 9.57e-04 | 6 | 167 | 2 | GO:1902396 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 9.58e-04 | 248 | 167 | 8 | GO:0120032 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.81e-07 | 32 | 167 | 6 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.81e-07 | 32 | 167 | 6 | GO:0043189 | |
| GeneOntologyCellularComponent | actin filament | 2.81e-07 | 146 | 167 | 10 | GO:0005884 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM2 TPM3 FILIP1 MYO9B POTEF SPTBN1 ACTB ANKRD26 ACTG1 SRCIN1 PSTPIP1 ADD1 MYO5C TWF1 POTEE POTEI EPB41L2 DNM2 | 8.83e-07 | 576 | 167 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.50e-06 | 45 | 167 | 6 | GO:1902562 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM2 TPM3 CENPE DSP MYO9B POTEF ACTB ACTG1 EVPL PSTPIP1 TWF1 POTEE IFFO2 DNM3 POTEI DNM1 MX1 WDR44 DNM2 PCNT DNAH11 | 1.04e-05 | 899 | 167 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | anchoring junction | RALA DSP ACTB OBSCN ACTG1 EVPL SRCIN1 PDPK2P GRHL2 GDI2 PABPC1 SLC2A2 ADD1 ADD3 TWF1 KIRREL3 ABCB11 PRKAR2A PRKCA CDH5 EPB41L2 DNM2 | 1.10e-05 | 976 | 167 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.39e-05 | 19 | 167 | 4 | GO:0098871 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.03e-05 | 104 | 167 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM2 TPM3 CENPE DSP MYO9B POTEF SYNE1 SPTBN1 ACTB OBSCN ACTG1 EVPL PSTPIP1 TWF1 POTEE IFFO2 DNM3 POTEI DNM1 MX1 WDR44 DNM2 PCNT DNAH11 | 2.29e-05 | 1179 | 167 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM2 TPM3 CENPE DSP MYO9B POTEF SYNE1 SPTBN1 ACTB OBSCN ACTG1 EVPL PSTPIP1 TWF1 POTEE IFFO2 DNM3 POTEI DNM1 MX1 WDR44 DNM2 PCNT DNAH11 | 2.56e-05 | 1187 | 167 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.75e-05 | 109 | 167 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 5.12e-05 | 26 | 167 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | axon | TPM3 RELN TRPM7 PACSIN1 USP9X POTEF SPTBN1 ACTB ACTG1 SRCIN1 POTEE KIRREL3 TENM3 LRP2 DNM3 PRKCA POTEI DNM1 DNM2 | 9.59e-05 | 891 | 167 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.08e-04 | 94 | 167 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | cell leading edge | TRPM7 PACSIN1 MYO9B SPTBN1 ACTB SRCIN1 PSTPIP1 ARFIP2 PABPC1 TWF1 KANK1 PABPC3 DNM2 | 1.98e-04 | 500 | 167 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | cell-cell junction | DSP ACTB OBSCN ACTG1 EVPL GRHL2 SLC2A2 ADD1 ADD3 TWF1 KIRREL3 ABCB11 PRKCA CDH5 | 2.92e-04 | 591 | 167 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 3.77e-04 | 4 | 167 | 2 | GO:0005862 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 4.04e-04 | 78 | 167 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 6.24e-04 | 5 | 167 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | focal adhesion | RALA ACTB ACTG1 SRCIN1 GDI2 PABPC1 ADD1 TWF1 PRKAR2A EPB41L2 DNM2 | 7.16e-04 | 431 | 167 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | RALA ACTB ACTG1 SRCIN1 GDI2 PABPC1 ADD1 TWF1 PRKAR2A EPB41L2 DNM2 | 8.96e-04 | 443 | 167 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 9.32e-04 | 6 | 167 | 2 | GO:0106002 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 9.32e-04 | 6 | 167 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.03e-03 | 254 | 167 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.04e-03 | 96 | 167 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | microtubule organizing center | USP9X CCDC18 ANKRD26 E2F1 RUVBL2 TTLL12 PLEKHG6 ARHGEF10 CEP95 CEP83 PRKAR2A PRKCA UXT ZBED1 TOP2A DNM2 PCNT | 1.13e-03 | 919 | 167 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | dense body | 1.30e-03 | 7 | 167 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | centrosome | USP9X CCDC18 ANKRD26 E2F1 RUVBL2 TTLL12 PLEKHG6 ARHGEF10 CEP95 CEP83 PRKAR2A UXT ZBED1 DNM2 PCNT | 1.34e-03 | 770 | 167 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | postsynapse | GABRB2 FILIP1 PACSIN1 MYO9B USP9X SYNE1 SPTBN1 ACTB ACTG1 SRCIN1 PDPK2P ADD1 ADD3 DNM3 DGCR8 UTRN PICK1 DNM2 | 1.34e-03 | 1018 | 167 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SYNRG RASA2 PACSIN1 MYO9B SYNE1 RPS6 PSTPIP1 ADD1 TWF1 BPTF DNM3 PRKAR2A PRKCA PICK1 MX1 WDR44 DNM2 | 1.34e-03 | 934 | 167 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | ruffle | 1.37e-03 | 206 | 167 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | cleavage furrow | 1.44e-03 | 61 | 167 | 4 | GO:0032154 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.48e-03 | 269 | 167 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | male pronucleus | 1.72e-03 | 8 | 167 | 2 | GO:0001940 | |
| GeneOntologyCellularComponent | myofilament | 2.10e-03 | 32 | 167 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.10e-03 | 32 | 167 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | granular component | 2.20e-03 | 9 | 167 | 2 | GO:0001652 | |
| GeneOntologyCellularComponent | spectrin | 2.20e-03 | 9 | 167 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.21e-03 | 287 | 167 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRB2 PACSIN1 SPTBN1 SRCIN1 PDPK2P ADD1 ADD3 DNM3 DGCR8 PICK1 DNM2 | 2.44e-03 | 503 | 167 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | cell projection membrane | PACSIN1 SPTBN1 SLC2A2 TWF1 KANK1 LRP2 UTRN DNM2 PHLPP2 BRWD1 | 2.51e-03 | 431 | 167 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | female pronucleus | 2.74e-03 | 10 | 167 | 2 | GO:0001939 | |
| GeneOntologyCellularComponent | calyx of Held | 2.95e-03 | 36 | 167 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | cell cortex | 3.05e-03 | 371 | 167 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 3.33e-03 | 11 | 167 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | postsynaptic density | PACSIN1 SPTBN1 SRCIN1 PDPK2P ADD1 ADD3 DNM3 DGCR8 PICK1 DNM2 | 3.46e-03 | 451 | 167 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.81e-03 | 129 | 167 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | ATPase complex | 3.81e-03 | 129 | 167 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | cell division site | 3.88e-03 | 80 | 167 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | RPAP3/R2TP/prefoldin-like complex | 3.97e-03 | 12 | 167 | 2 | GO:1990062 | |
| GeneOntologyCellularComponent | podosome | 4.27e-03 | 41 | 167 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | CCZ1B NAA15 POTEF ACTB USP25 ACTG1 RUVBL2 RNF14 POTEE CCZ1 UCHL5 CEP83 PRKAR2A DGCR8 UXT POTEI | 4.96e-03 | 972 | 167 | 16 | GO:0140535 |
| GeneOntologyCellularComponent | presynapse | GABRB2 TRPM7 PACSIN1 RPS6 ACTB ACTG1 SRCIN1 KIRREL3 TENM3 OTOF DNM3 PRKCA DNM1 PICK1 DNM2 | 5.03e-03 | 886 | 167 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | asymmetric synapse | PACSIN1 SPTBN1 SRCIN1 PDPK2P ADD1 ADD3 DNM3 DGCR8 PICK1 DNM2 | 5.11e-03 | 477 | 167 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | uropod | 5.42e-03 | 14 | 167 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | contractile ring | 5.42e-03 | 14 | 167 | 2 | GO:0070938 | |
| GeneOntologyCellularComponent | ISWI-type complex | 5.42e-03 | 14 | 167 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRB2 FILIP1 PACSIN1 SPTBN1 ACTB SRCIN1 TENM4 TENM3 DNM3 PRKAR2A DGCR8 DNM1 PICK1 DNM2 | 6.01e-03 | 817 | 167 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | cell trailing edge | 6.22e-03 | 15 | 167 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | varicosity | 6.22e-03 | 15 | 167 | 2 | GO:0043196 | |
| GeneOntologyCellularComponent | myofibril | 6.47e-03 | 273 | 167 | 7 | GO:0030016 | |
| Domain | Dynamin_central | 7.87e-08 | 6 | 161 | 4 | IPR000375 | |
| Domain | GED | 7.87e-08 | 6 | 161 | 4 | SM00302 | |
| Domain | Dynamin_M | 7.87e-08 | 6 | 161 | 4 | PF01031 | |
| Domain | GED_dom | 7.87e-08 | 6 | 161 | 4 | IPR020850 | |
| Domain | GED | 7.87e-08 | 6 | 161 | 4 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 7.87e-08 | 6 | 161 | 4 | IPR019762 | |
| Domain | GED | 7.87e-08 | 6 | 161 | 4 | PF02212 | |
| Domain | GED | 7.87e-08 | 6 | 161 | 4 | IPR003130 | |
| Domain | Actin_CS | 1.81e-07 | 16 | 161 | 5 | IPR004001 | |
| Domain | G_DYNAMIN_1 | 1.82e-07 | 7 | 161 | 4 | PS00410 | |
| Domain | DYNc | 1.82e-07 | 7 | 161 | 4 | SM00053 | |
| Domain | ACTINS_2 | 2.55e-07 | 17 | 161 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 3.50e-07 | 18 | 161 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 4.72e-07 | 19 | 161 | 5 | PS01132 | |
| Domain | P-loop_NTPase | RALA RALB CENPE MYO9B GIMAP7 RUVBL2 MYO5C ARHGAP5 SULT2A1 DGUOK DNM3 ABCB11 CHST2 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 3.85e-06 | 848 | 161 | 22 | IPR027417 |
| Domain | Spectrin_repeat | 4.49e-06 | 29 | 161 | 5 | IPR002017 | |
| Domain | G_DYNAMIN_dom | 4.98e-06 | 14 | 161 | 4 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 4.98e-06 | 14 | 161 | 4 | PS51718 | |
| Domain | Actin | 6.34e-06 | 31 | 161 | 5 | IPR004000 | |
| Domain | Actin | 6.34e-06 | 31 | 161 | 5 | PF00022 | |
| Domain | ACTIN | 6.34e-06 | 31 | 161 | 5 | SM00268 | |
| Domain | Dynamin_GTPase | 6.74e-06 | 15 | 161 | 4 | IPR001401 | |
| Domain | Dynamin_SF | 6.74e-06 | 15 | 161 | 4 | IPR022812 | |
| Domain | Dynamin_N | 6.74e-06 | 15 | 161 | 4 | PF00350 | |
| Domain | SPEC | 7.46e-06 | 32 | 161 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.46e-06 | 32 | 161 | 5 | IPR018159 | |
| Domain | PH_dom-like | RASA2 SPTBN1 VEPH1 OBSCN ARHGEF18 VPS36 AFAP1L2 PLEKHG6 ARHGEF10 DNM3 DNM1 EPB41L2 DNM2 PHLPP2 | 2.00e-05 | 426 | 161 | 14 | IPR011993 |
| Domain | - | RALA RALB GIMAP7 RUVBL2 ARHGAP5 SULT2A1 DGUOK DNM3 ABCB11 CHST2 ASCC3 DNM1 ABCD2 DDX24 MOV10 MX1 DNM2 DNAH11 RASD2 | 2.40e-05 | 746 | 161 | 19 | 3.40.50.300 |
| Domain | PH_DOMAIN | RASA2 SPTBN1 VEPH1 OBSCN ARHGEF18 AFAP1L2 PLEKHG6 DNM3 DNM1 DNM2 PHLPP2 | 3.12e-05 | 279 | 161 | 11 | PS50003 |
| Domain | DUF1712 | 7.39e-05 | 2 | 161 | 2 | PF08217 | |
| Domain | DUF1712_fun | 7.39e-05 | 2 | 161 | 2 | IPR013176 | |
| Domain | Ral | 7.39e-05 | 2 | 161 | 2 | IPR028412 | |
| Domain | - | RASA2 SPTBN1 VEPH1 OBSCN ARHGEF18 AFAP1L2 PLEKHG6 DNM3 DNM1 EPB41L2 DNM2 PHLPP2 | 1.51e-04 | 391 | 161 | 12 | 2.30.29.30 |
| Domain | PH | RASA2 SPTBN1 VEPH1 OBSCN ARHGEF18 AFAP1L2 PLEKHG6 DNM3 DNM1 DNM2 | 1.53e-04 | 278 | 161 | 10 | SM00233 |
| Domain | PH_domain | RASA2 SPTBN1 VEPH1 OBSCN ARHGEF18 AFAP1L2 PLEKHG6 DNM3 DNM1 DNM2 | 1.62e-04 | 280 | 161 | 10 | IPR001849 |
| Domain | PH | 1.70e-04 | 229 | 161 | 9 | PF00169 | |
| Domain | Rhs_assc_core | 2.20e-04 | 3 | 161 | 2 | IPR022385 | |
| Domain | Arfaptin_fam | 2.20e-04 | 3 | 161 | 2 | IPR030798 | |
| Domain | Tox-GHH_dom | 4.38e-04 | 4 | 161 | 2 | IPR028916 | |
| Domain | TROPOMYOSIN | 4.38e-04 | 4 | 161 | 2 | PS00326 | |
| Domain | Tropomyosin | 4.38e-04 | 4 | 161 | 2 | IPR000533 | |
| Domain | Tox-GHH | 4.38e-04 | 4 | 161 | 2 | PF15636 | |
| Domain | Aldolase_II | 4.38e-04 | 4 | 161 | 2 | SM01007 | |
| Domain | Aldolase_II/adducin_N | 4.38e-04 | 4 | 161 | 2 | IPR001303 | |
| Domain | Ten_N | 4.38e-04 | 4 | 161 | 2 | IPR009471 | |
| Domain | Ten_N | 4.38e-04 | 4 | 161 | 2 | PF06484 | |
| Domain | Aldolase_II | 4.38e-04 | 4 | 161 | 2 | PF00596 | |
| Domain | TENEURIN_N | 4.38e-04 | 4 | 161 | 2 | PS51361 | |
| Domain | - | 4.38e-04 | 4 | 161 | 2 | 3.40.225.10 | |
| Domain | Tropomyosin | 4.38e-04 | 4 | 161 | 2 | PF00261 | |
| Domain | DDT | 7.26e-04 | 5 | 161 | 2 | SM00571 | |
| Domain | PolyA | 7.26e-04 | 5 | 161 | 2 | SM00517 | |
| Domain | - | 7.26e-04 | 5 | 161 | 2 | 1.10.1900.10 | |
| Domain | AH_dom | 7.26e-04 | 5 | 161 | 2 | IPR010504 | |
| Domain | PABP | 7.26e-04 | 5 | 161 | 2 | PF00658 | |
| Domain | DDT_dom | 7.26e-04 | 5 | 161 | 2 | IPR018501 | |
| Domain | YD | 7.26e-04 | 5 | 161 | 2 | IPR006530 | |
| Domain | PABP_1234 | 7.26e-04 | 5 | 161 | 2 | IPR006515 | |
| Domain | Arfaptin | 7.26e-04 | 5 | 161 | 2 | SM01015 | |
| Domain | WHIM1_dom | 7.26e-04 | 5 | 161 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 7.26e-04 | 5 | 161 | 2 | IPR028941 | |
| Domain | WSD | 7.26e-04 | 5 | 161 | 2 | PF15613 | |
| Domain | WHIM1 | 7.26e-04 | 5 | 161 | 2 | PF15612 | |
| Domain | PABC | 7.26e-04 | 5 | 161 | 2 | PS51309 | |
| Domain | Arfaptin | 7.26e-04 | 5 | 161 | 2 | PF06456 | |
| Domain | PABP_HYD | 7.26e-04 | 5 | 161 | 2 | IPR002004 | |
| Domain | AH | 7.26e-04 | 5 | 161 | 2 | PS50870 | |
| Domain | DS_RBD | 7.46e-04 | 21 | 161 | 3 | PS50137 | |
| Domain | Spectrin | 9.81e-04 | 23 | 161 | 3 | PF00435 | |
| Domain | ACTININ_2 | 9.81e-04 | 23 | 161 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.81e-04 | 23 | 161 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.81e-04 | 23 | 161 | 3 | IPR001589 | |
| Domain | DDT | 1.08e-03 | 6 | 161 | 2 | PS50827 | |
| Domain | - | 1.08e-03 | 6 | 161 | 2 | 3.90.1290.10 | |
| Domain | Bromodomain_CS | 1.41e-03 | 26 | 161 | 3 | IPR018359 | |
| Domain | Plectin | 1.51e-03 | 7 | 161 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.51e-03 | 7 | 161 | 2 | IPR001101 | |
| Domain | PLEC | 1.51e-03 | 7 | 161 | 2 | SM00250 | |
| Domain | - | 1.58e-03 | 27 | 161 | 3 | 3.30.160.20 | |
| Domain | dsRBD_dom | 1.76e-03 | 28 | 161 | 3 | IPR014720 | |
| Domain | EGF_extracell | 1.78e-03 | 60 | 161 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.78e-03 | 60 | 161 | 4 | PF07974 | |
| Domain | ACTINS_1 | 2.00e-03 | 8 | 161 | 2 | PS00406 | |
| Domain | DH_1 | 2.13e-03 | 63 | 161 | 4 | PS00741 | |
| Domain | RhoGEF | 2.82e-03 | 68 | 161 | 4 | SM00325 | |
| Domain | RhoGEF | 3.14e-03 | 70 | 161 | 4 | PF00621 | |
| Domain | DH_2 | 3.14e-03 | 70 | 161 | 4 | PS50010 | |
| Domain | - | 3.30e-03 | 71 | 161 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.30e-03 | 71 | 161 | 4 | IPR000219 | |
| Domain | - | 3.30e-03 | 71 | 161 | 4 | 1.10.418.10 | |
| Domain | RAS | 3.36e-03 | 35 | 161 | 3 | PS51421 | |
| Domain | Small_GTPase_Ras | 3.94e-03 | 37 | 161 | 3 | IPR020849 | |
| Domain | BROMODOMAIN_1 | 3.94e-03 | 37 | 161 | 3 | PS00633 | |
| Domain | CH-domain | 4.02e-03 | 75 | 161 | 4 | IPR001715 | |
| Domain | Bromodomain | 4.25e-03 | 38 | 161 | 3 | PF00439 | |
| Domain | - | 4.58e-03 | 39 | 161 | 3 | 2.120.10.30 | |
| Domain | BROMODOMAIN_2 | 5.27e-03 | 41 | 161 | 3 | PS50014 | |
| Domain | NHL | 5.41e-03 | 13 | 161 | 2 | PS51125 | |
| Domain | Bromodomain | 5.64e-03 | 42 | 161 | 3 | IPR001487 | |
| Domain | BROMO | 5.64e-03 | 42 | 161 | 3 | SM00297 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM3 FILIP1 DSP MYO9B USP9X SPTBN1 ACTB OBSCN ANKRD26 ACTG1 ARHGEF18 ADD3 TWF1 POTEE ARHGAP5 PLEKHG6 ARHGEF10 MTR | 2.86e-07 | 450 | 135 | 18 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM3 FILIP1 NUP85 CENPE DSP MYO9B USP9X SPTBN1 ACTB OBSCN ANKRD26 ACTG1 ARHGEF18 PDPK2P ADD3 TWF1 ARHGAP5 PLEKHG6 ARHGEF10 MTR SFN | 9.04e-07 | 649 | 135 | 21 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM3 FILIP1 DSP MYO9B USP9X SPTBN1 ACTB OBSCN ANKRD26 ACTG1 ARHGEF18 ADD3 TWF1 ARHGAP5 PLEKHG6 ARHGEF10 MTR | 9.87e-07 | 439 | 135 | 17 | MM15595 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM3 FILIP1 NUP85 CENPE DSP MYO9B USP9X SPTBN1 ACTB OBSCN ANKRD26 ACTG1 ARHGEF18 ADD3 TWF1 POTEE ARHGAP5 PLEKHG6 ARHGEF10 MTR PRKCA SFN | 1.25e-06 | 720 | 135 | 22 | M41838 |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 2.52e-06 | 11 | 135 | 4 | MM14732 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 3.75e-06 | 12 | 135 | 4 | M15243 | |
| Pathway | PID_RHOA_REG_PATHWAY | 4.72e-06 | 46 | 135 | 6 | M68 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.55e-05 | 37 | 135 | 5 | MM15102 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 4.25e-05 | 41 | 135 | 5 | MM15630 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.64e-05 | 68 | 135 | 6 | MM14968 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 4.79e-05 | 42 | 135 | 5 | M41821 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 6.18e-05 | 23 | 135 | 4 | MM1470 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 9.37e-05 | 77 | 135 | 6 | M41822 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.81e-05 | 10 | 135 | 3 | MM15112 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.02e-04 | 49 | 135 | 5 | M891 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 1.77e-04 | 55 | 135 | 5 | M41823 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.28e-04 | 58 | 135 | 5 | M11980 | |
| Pathway | BIOCARTA_AKAPCENTROSOME_PATHWAY | 2.89e-04 | 14 | 135 | 3 | M15347 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 2.89e-04 | 14 | 135 | 3 | M10122 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | RALA CCZ1B CENPE PACSIN1 SPTBN1 ACTB ACTG1 VPS36 ARFIP2 GDI2 CCZ1 LRP2 DNM3 DNM1 DNM2 SFN | 3.43e-04 | 630 | 135 | 16 | M11480 |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 4.30e-04 | 142 | 135 | 7 | MM15499 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 4.48e-04 | 143 | 135 | 7 | M39591 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 4.87e-04 | 145 | 135 | 7 | M27753 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 5.63e-04 | 40 | 135 | 4 | MM15060 | |
| Pathway | WP_THERMOGENESIS | 5.94e-04 | 108 | 135 | 6 | M39746 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 7.25e-04 | 155 | 135 | 7 | M522 | |
| Pathway | WP_FARNESOID_X_RECEPTOR_PATHWAY | 7.44e-04 | 19 | 135 | 3 | M39411 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 8.11e-04 | 44 | 135 | 4 | MM14606 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 RALA ILF3 NUP85 DSP MYO9B FBL USP9X SYNE1 RPS6 BAZ1B ACTG1 LRRC40 RUVBL2 PABPC1 MYO5C BPTF CRNKL1 EIF2S1 NUP210 CBX1 PRKCA ASCC3 UTRN TOP2A EPB41L2 PCNT | 6.66e-13 | 1024 | 167 | 27 | 24711643 |
| Pubmed | TPM3 RALA DPP6 ILF3 DSP PACSIN1 USP9X SYNE1 RPS6 SPTBN1 ACTB POR ACTG1 SRCIN1 GDI2 PABPC1 ADD1 ADD3 TWF1 ARHGAP5 TENM4 EIF2S1 PABPC3 CRACDL PRKAR2A PRKCA DNM1 UTRN EPB41L2 DNM2 DNAH11 | 1.81e-12 | 1431 | 167 | 31 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM3 RALA ILF3 NAA15 NUP85 NOP16 DSP FBL RPS6 SPTBN1 ACTB BAZ1B EVPL RUVBL2 PABPC1 ADD1 ADD3 TWF1 CRNKL1 EIF2S1 CLK3 NUP210 CBX1 ASCC3 DDX24 TOP2A EPB41L2 MOV10 SFN | 2.27e-12 | 1257 | 167 | 29 | 36526897 |
| Pubmed | ILF3 NAA15 NUP85 FBL USP9X SPTBN1 ACTB LRRC40 RUVBL2 PABPC1 ADD1 ADD3 TTLL12 CRNKL1 IPO9 EIF2S1 NUP210 PRKAR2A ASCC3 EPB41L2 DNM2 | 5.10e-12 | 638 | 167 | 21 | 33239621 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 RALA ILF3 DSP FBL USP9X SYNE1 RPS6 SPTBN1 RBM26 POR BAZ1B ACTG1 LRRC40 RUVBL2 GDI2 PABPC1 TTLL12 CRNKL1 IPO9 EIF2S1 UCHL5 NUP210 MTR PRKAR2A CHST2 ITM2B DDX24 TOP2A EPB41L2 | 8.83e-12 | 1425 | 167 | 30 | 30948266 |
| Pubmed | TPM2 TPM3 RALA RALB ILF3 NUP85 DSP POTEF SYNE1 RPS6 SPTBN1 ACTB ANKRD26 DNAJC18 ACTG1 VPS36 PABPC1 CCDC148 POTEE BPTF PXDN PABPC3 CEP83 POTEI CCDC89 OBI1 TOP2A PICK1 SFN PCNT | 1.18e-11 | 1442 | 167 | 30 | 35575683 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM2 TPM3 ILF3 NAA15 DSP USP9X RPS6 SPTBN1 ACTB ACTG1 RUVBL2 PABPC1 TWF1 IPO9 EIF2S1 PABPC3 DNM3 UTRN EPB41L2 DNM2 SFN PCNT BRWD1 | 2.23e-11 | 847 | 167 | 23 | 35235311 |
| Pubmed | NAA15 DSP FBL USP9X RPS6 SPTBN1 BAZ1B GDI2 PABPC1 TTLL12 BPTF CRNKL1 NUP210 ASCC3 DDX24 UTRN EPB41L2 MOV10 DNM2 PCNT | 6.09e-11 | 653 | 167 | 20 | 22586326 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM2 TPM3 NAA15 NUP85 USP9X RPS6 SPTBN1 USP25 ACTG1 VPS36 ARFIP2 RUVBL2 GDI2 PABPC1 TWF1 TTLL12 IPO9 ARHGEF10 EIF2S1 UCHL5 MTR PRKAR2A UROD DNM1 CDC34 VPS29 EPB41L2 WDR44 SFN | 7.53e-11 | 1455 | 167 | 29 | 22863883 |
| Pubmed | TPM2 TPM3 NAA15 FBL USP9X POTEF RPS6 CDKN2AIP SPTBN1 ACTB PABPC1 TWF1 IPO9 EIF2S1 UTRN TOP2A MOV10 SFN | 1.43e-10 | 538 | 167 | 18 | 28524877 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM3 SYNRG SIN3B ILF3 NAA15 DSP RPS6 CDKN2AIP RNF113A RBM26 ANKRD26 BAZ1B PABPC1 ADD1 ADD3 TWF1 CBX1 UTRN TOP2A EPB41L2 WDR44 DNM2 PCNT | 1.53e-10 | 934 | 167 | 23 | 33916271 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SIN3B ILF3 POTEF SPTBN1 ACTB RBM26 ACTG1 PSTPIP1 RUVBL2 POTEE BPTF POTEI TOP2A | 7.88e-10 | 271 | 167 | 13 | 32433965 |
| Pubmed | TPM2 ILF3 DSP FBL CDKN2AIP SPTBN1 ACTB RBM26 RUVBL2 PABPC1 ADD1 EIF2S1 TOP2A MOV10 | 1.25e-09 | 340 | 167 | 14 | 24332808 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM3 ILF3 NAA15 DSP USP9X RPS6 SPTBN1 ACTB RBM26 RUVBL2 GDI2 PABPC1 ADD1 TTLL12 IPO9 EIF2S1 UCHL5 PRKAR2A ASCC3 OBI1 VPS29 EPB41L2 MOV10 DNM2 | 1.57e-09 | 1149 | 167 | 24 | 35446349 |
| Pubmed | SIN3B ILF3 FOXP2 CENPE USP9X SYNE1 SPTBN1 ACTB ARHGEF18 GDI2 PABPC1 ADD1 TWF1 PABPC3 ZNF516 DNM3 PRKAR2A PRKCA DNM1 EPB41L2 DNM2 PCNT | 1.59e-09 | 963 | 167 | 22 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 ILF3 NAA15 RASA2 DSP MYO9B FBL RPS6 SPTBN1 ACTB BAZ1B LRRC40 RUVBL2 PABPC1 CRNKL1 IPO9 MRPL14 EIF2S1 CBX1 PRKCA ASCC3 DDX24 UTRN TOP2A EPB41L2 MOV10 | 1.75e-09 | 1353 | 167 | 26 | 29467282 |
| Pubmed | RELN CFAP91 TRPM7 DSP USP9X SYNE1 SPTBN1 ACTB USP25 ADD3 TTLL12 ARHGAP5 CRNKL1 OTOF ARHGEF10 LRP2 DNM3 DGCR8 UROD DNM1 UTRN PICK1 DNM2 PCNT BRWD1 | 2.91e-09 | 1285 | 167 | 25 | 35914814 | |
| Pubmed | TPM3 SIN3B NOP16 USP9X RPS6 ACTB ACTG1 PRPH2 PABPC1 SLC2A2 PABPC3 CDH5 | 5.33e-09 | 259 | 167 | 12 | 9811942 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM2 TPM3 ILF3 NOP16 DSP FBL SYNE1 RPS6 SPTBN1 ACTB ACTG1 PABPC1 MYO5C TWF1 CRNKL1 PXDN MRPL14 EIF2S1 CLK3 TOP2A MOV10 | 6.71e-09 | 949 | 167 | 21 | 36574265 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 6.94e-09 | 15 | 167 | 5 | 16824795 | |
| Pubmed | TPM3 SIN3B NOP16 SYNE1 CDKN2AIP CLK4 ACTB RBM26 BAZ1B CREB3L4 TWF1 POTEE CRNKL1 PXDN EIF2S1 CLK3 CRACDL CEP83 CBX1 PRKAR2A DGCR8 ASCC3 ITM2B UTRN EPB41L2 MOV10 | 1.39e-08 | 1497 | 167 | 26 | 31527615 | |
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 15252009 | ||
| Pubmed | TPM2 TPM3 RPS6 SPTBN1 ACTG1 SRCIN1 ADD3 IPO9 EIF2S1 CRACDL PRKCA | 1.94e-08 | 233 | 167 | 11 | 29518331 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCZ1B ILF3 DSP CDKN2AIP SPTBN1 ACTB LRRC40 VPS36 RUVBL2 TWF1 IPO9 CCZ1 UCHL5 TOP2A DNM2 PCNT | 2.51e-08 | 582 | 167 | 16 | 20467437 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TPM3 SYNRG CENPE DSP ANKRD26 ACTG1 ARFIP2 RUVBL2 GDI2 ARHGAP5 MRPL14 CEP95 IFFO2 LRP2 PRKCA TOP2A VPS29 PCNT BRWD1 | 3.34e-08 | 853 | 167 | 19 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG NAA15 TRPM7 DSP POTEF SPTBN1 CCDC18 ANKRD26 PABPC1 TWF1 TTLL12 IPO9 ARHGEF10 CEP95 CLK3 UTRN OBI1 EPB41L2 SFN | 3.87e-08 | 861 | 167 | 19 | 36931259 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CCZ1B ILF3 NUP85 DSP FBL USP9X RPS6 ACTB ACTG1 RUVBL2 GDI2 PABPC1 CCZ1 EIF2S1 UCHL5 PABPC3 NUP210 MTR PRKAR2A UXT ASCC3 DNM2 SFN | 4.09e-08 | 1257 | 167 | 23 | 37317656 |
| Pubmed | ILF3 NAA15 NUP85 CENPE MYO9B USP9X RPS6 ACTB POR ACTG1 LRRC40 PSTPIP1 PABPC1 IPO9 EIF2S1 CLK3 NUP210 PRKAR2A ASCC3 ITM2B DDX24 PCNT | 5.01e-08 | 1168 | 167 | 22 | 19946888 | |
| Pubmed | CCPG1 ILF3 NAA15 TRPM7 SYNE1 SPTBN1 CCDC18 ANKRD26 POR DNAJC18 BAZ1B LRRC40 ADD1 ADD3 TTLL12 ARHGEF10 EIF2S1 NUP210 MTR PRKAR2A ASCC3 ITM2B DDX24 EPB41L2 PCNT | 5.11e-08 | 1487 | 167 | 25 | 33957083 | |
| Pubmed | ILF3 FBL ACTB ACTG1 ARHGEF18 LRRC40 RUVBL2 PABPC1 IPO9 UCHL5 UXT MOV10 DNM2 | 5.99e-08 | 390 | 167 | 13 | 17643375 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | TPM3 FOXP2 RPS6 SPTBN1 ACTB USP25 POR SRCIN1 PABPC1 ADD1 ADD3 PABPC3 DNM1 EPB41L2 DNM2 SFN | 6.11e-08 | 621 | 167 | 16 | 22794259 |
| Pubmed | ILF3 NAA15 NOP16 DSP FBL CDKN2AIP SPTBN1 ACTB ACTG1 RUVBL2 PABPC1 ADD1 TTLL12 POTEE EIF2S1 UTRN DNM2 | 6.76e-08 | 711 | 167 | 17 | 33022573 | |
| Pubmed | SYNRG SIN3B DSP FBL USP9X RBM26 BAZ1B ACTG1 RUVBL2 ADD1 ADD3 BPTF ASCC3 TOP2A WDR44 | 7.57e-08 | 549 | 167 | 15 | 38280479 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | TPM2 TPM3 ILF3 ACTB POR ACTG1 RUVBL2 PABPC1 MYO5C ASCC3 UTRN | 8.09e-08 | 268 | 167 | 11 | 33024031 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM3 RALB ILF3 NAA15 NOP16 DSP FBL USP9X RPS6 SPTBN1 ACTB RBM26 ACTG1 LRRC40 RUVBL2 PABPC1 CRNKL1 MRPL14 EIF2S1 UXT DDX24 TOP2A EPB41L2 SFN | 8.29e-08 | 1415 | 167 | 24 | 28515276 |
| Pubmed | RALA ILF3 FBL USP9X RPS6 SPTBN1 ACTB BAZ1B GDI2 PABPC1 EIF2S1 ASCC3 TOP2A EPB41L2 | 1.05e-07 | 484 | 167 | 14 | 31995728 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 12511974 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 12383797 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 24273169 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 1.09e-07 | 3 | 167 | 3 | 28395327 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 1.09e-07 | 3 | 167 | 3 | 24046449 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM2 TPM3 RALA RALB DSP POTEF RPS6 SPTBN1 ACTB PABPC1 ADD1 TWF1 POTEE EIF2S1 EPB41L2 | 1.53e-07 | 580 | 167 | 15 | 35676659 |
| Pubmed | TPM3 ILF3 NOP16 MYO9B FBL RPS6 SPTBN1 ACTG1 RUVBL2 GDI2 PABPC1 ADD1 CRNKL1 KANK1 IPO9 EIF2S1 PRKAR2A ASCC3 DDX24 TOP2A DNM2 SFN | 1.55e-07 | 1247 | 167 | 22 | 27684187 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG CENPE DSP MYO9B FBL USP9X ANKRD26 BAZ1B RUVBL2 POTEE ZNF516 MTR POTEI OBI1 PCNT | 1.83e-07 | 588 | 167 | 15 | 38580884 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | FOXP2 CLK4 RNF113A E2F1 EXT1 PABPC1 TENM3 CLK3 PRKCA DDX24 TOP2A MOV10 | 1.85e-07 | 358 | 167 | 12 | 32460013 |
| Pubmed | TPM2 TPM3 RALA ILF3 NOP16 DSP FBL SPTBN1 RBM26 LRRC40 RUVBL2 PABPC1 ADD1 ADD3 ARHGAP5 CRNKL1 IPO9 SULT2A1 UCHL5 ASCC3 EPB41L2 MOV10 MAJIN | 1.92e-07 | 1371 | 167 | 23 | 36244648 | |
| Pubmed | TPM2 TPM3 ILF3 RPS6 SPTBN1 ACTB ACTG1 PABPC1 ADD1 TWF1 DDX24 | 2.12e-07 | 295 | 167 | 11 | 26209609 | |
| Pubmed | 2.20e-07 | 234 | 167 | 10 | 36243803 | ||
| Pubmed | TPM2 TPM3 NOP16 MYO9B FBL RPS6 BAZ1B RUVBL2 IPO9 ARHGEF10 EIF2S1 ASCC3 TOP2A DNM2 SFN | 2.42e-07 | 601 | 167 | 15 | 33658012 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | RALA RALB POTEF ACTB ACTG1 VPS36 GDI2 PABPC1 MYO5C POTEE PXDN PABPC3 LRP2 DNM3 PRKAR2A POTEI DNM1 ITM2B DNM2 SFN | 2.42e-07 | 1070 | 167 | 20 | 23533145 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ILF3 NOP16 FBL SYNE1 SPTBN1 RBM26 GDI2 PABPC1 CRNKL1 MRPL14 EIF2S1 CLK3 ASCC3 DNM1 DDX24 TOP2A MOV10 | 4.01e-07 | 807 | 167 | 17 | 22681889 |
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 4.33e-07 | 4 | 167 | 3 | 21689597 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 22846998 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 9108196 | ||
| Pubmed | Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. | 4.33e-07 | 4 | 167 | 3 | 24129315 | |
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 4.94e-07 | 14 | 167 | 4 | 20802490 | |
| Pubmed | TPM3 ILF3 DSP USP9X RPS6 CDKN2AIP SPTBN1 ACTB RUVBL2 PABPC1 TWF1 CRNKL1 OBI1 MOV10 | 5.00e-07 | 551 | 167 | 14 | 34728620 | |
| Pubmed | ILF3 NOP16 DSP FBL RPS6 SPTBN1 ACTG1 RUVBL2 CRNKL1 MRPL14 EIF2S1 CLK3 DDX24 TOP2A MOV10 SFN | 5.43e-07 | 731 | 167 | 16 | 29298432 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | TPM3 SYNRG ILF3 RPS6 SRCIN1 RUVBL2 GDI2 PABPC1 ADD1 ADD3 MRPL14 PRKAR2A DGCR8 DNM1 | 5.81e-07 | 558 | 167 | 14 | 35063084 |
| Pubmed | TPM3 ILF3 RPS6 SPTBN1 EVPL GDI2 PABPC1 POTEE PRKCA TOP2A SFN | 5.89e-07 | 327 | 167 | 11 | 31409639 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM2 DSP SPTBN1 RUVBL2 GDI2 PABPC1 IPO9 PXDN PABPC3 NUP210 TOP2A MOV10 MX1 DNM2 SFN | 6.12e-07 | 647 | 167 | 15 | 26618866 |
| Pubmed | ILF3 DSP FBL RPS6 ACTB RUVBL2 GDI2 PABPC1 TTLL12 ASCC3 TOP2A | 6.44e-07 | 330 | 167 | 11 | 32529326 | |
| Pubmed | ILF3 DSP FBL SPTBN1 ACTB BAZ1B ACTG1 EVPL RUVBL2 PABPC1 POTEE NUP210 CBX1 TOP2A SFN | 6.73e-07 | 652 | 167 | 15 | 31180492 | |
| Pubmed | TPM2 MYO9B USP9X RPS6 SPTBN1 BAZ1B LIF PXDN MRPL14 ARHGEF10 TOP2A | 6.83e-07 | 332 | 167 | 11 | 37433992 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | CCDC60 ILF3 DSP SYNE1 RPS6 CDKN2AIP SPTBN1 ACTB OBSCN PABPC1 ABCB11 | 7.03e-07 | 333 | 167 | 11 | 32665550 |
| Pubmed | RALA ILF3 DSP SPTBN1 ACTB OBSCN ACTG1 TWF1 EIF2S1 POTEI EPB41L2 | 7.24e-07 | 334 | 167 | 11 | 30425250 | |
| Pubmed | TPM3 SLC27A6 DSP USP9X RPS6 SPTBN1 ACTB ACTG1 RUVBL2 PABPC1 EIF2S1 PRKAR2A SFN | 7.68e-07 | 488 | 167 | 13 | 31324722 | |
| Pubmed | ILF3 NUP85 FBL SPTBN1 ACTB BAZ1B ACTG1 RUVBL2 PABPC1 TWF1 POTEE EIF2S1 CBX1 TOP2A EPB41L2 | 7.84e-07 | 660 | 167 | 15 | 32780723 | |
| Pubmed | ILF3 DSP USP9X RPS6 CDKN2AIP ACTB ACTG1 RUVBL2 PABPC1 MOV10 MX1 | 1.02e-06 | 346 | 167 | 11 | 25324306 | |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 9722593 | ||
| Pubmed | 1.09e-06 | 159 | 167 | 8 | 22751105 | ||
| Pubmed | TPM2 RALA MTF2 SPTBN1 ACTB USP25 ACTG1 RNF14 ARHGAP5 KANK1 TENM3 ASCC3 UTRN DNM2 | 1.14e-06 | 591 | 167 | 14 | 15231748 | |
| Pubmed | POTEF SPTBN1 RNF113A ACTB RUVBL2 PABPC1 ADD1 ADD3 TWF1 CRNKL1 EIF2S1 POTEI UTRN | 1.15e-06 | 506 | 167 | 13 | 30890647 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | USP9X SYNE1 SPTBN1 ARHGEF18 SRCIN1 GDI2 PRKAR2A PRKCA DNM1 EPB41L2 | 1.17e-06 | 281 | 167 | 10 | 28706196 |
| Pubmed | 1.45e-06 | 223 | 167 | 9 | 20020773 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | TPM2 DSP POTEF SPTBN1 ACTB PABPC1 POTEE PABPC3 POTEI EPB41L2 | 1.46e-06 | 288 | 167 | 10 | 31501420 |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | RALA ILF3 DSP FBL RPS6 SPTBN1 ACTB ADD1 ADD3 UCHL5 CBX1 PRKAR2A TOP2A EPB41L2 | 1.48e-06 | 604 | 167 | 14 | 37616343 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ILF3 DSP FBL RPS6 SPTBN1 ACTB BAZ1B ACTG1 PABPC1 EIF2S1 CBX1 ASCC3 DDX24 TOP2A | 1.50e-06 | 605 | 167 | 14 | 28977666 |
| Pubmed | 1.56e-06 | 116 | 167 | 7 | 21282530 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TPM3 ILF3 NUP85 FBL RPS6 CDKN2AIP ACTB BAZ1B LRRC40 RUVBL2 PABPC1 ADD1 CRNKL1 IPO9 EIF2S1 CBX1 ASCC3 DDX24 TOP2A MOV10 DNM2 | 1.56e-06 | 1318 | 167 | 21 | 30463901 |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 1.77e-06 | 42 | 167 | 5 | 14760703 | |
| Pubmed | ILF3 NOP16 FBL USP9X RPS6 ACTG1 RUVBL2 PABPC1 EIF2S1 DGCR8 UXT ASCC3 TOP2A MOV10 | 1.82e-06 | 615 | 167 | 14 | 31048545 | |
| Pubmed | TPM3 ILF3 NAA15 FBL RPS6 SPTBN1 ACTB RUVBL2 GDI2 PABPC1 TTLL12 EIF2S1 NUP210 TOP2A DNM2 | 1.83e-06 | 707 | 167 | 15 | 19738201 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.94e-06 | 231 | 167 | 9 | 16452087 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 23640057 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 27251629 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 18602423 | ||
| Pubmed | 2.34e-06 | 20 | 167 | 4 | 18723693 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 2.48e-06 | 238 | 167 | 9 | 35864588 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SIN3B CENPE DSP OBSCN EVPL LRRC40 GIMAP7 TTLL12 POTEE ARHGAP5 AFAP1L2 CEP95 LRP2 UTRN EPB41L2 | 2.99e-06 | 736 | 167 | 15 | 29676528 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | TPM3 DSP RPS6 SPTBN1 OBSCN ACTG1 RUVBL2 POTEE IPO9 PABPC3 PRKAR2A EPB41L2 | 3.06e-06 | 468 | 167 | 12 | 36042349 |
| Pubmed | ILF3 NOP16 DSP FBL USP9X POTEF RPS6 ACTB ACTG1 LRRC40 RUVBL2 PABPC1 POTEE MRPL14 EIF2S1 PABPC3 NUP210 POTEI MOV10 | 3.15e-06 | 1153 | 167 | 19 | 29845934 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM3 ILF3 NAA15 NUP85 CENPE TRPM7 FBL SYNE1 POR LRRC40 GDI2 POTEE MRPL14 LRP2 MTR PRKAR2A ACOT2 DDX24 TOP2A MOV10 WDR44 PCNT | 3.17e-06 | 1496 | 167 | 22 | 32877691 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ILF3 NAA15 NUP85 CENPE FBL SYNE1 CDKN2AIP RUVBL2 GDI2 PABPC1 TTLL12 CRNKL1 KANK1 IFFO2 CBX1 PRKAR2A OBI1 TOP2A MOV10 | 3.23e-06 | 1155 | 167 | 19 | 20360068 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | FBL SPTBN1 RBM26 RUVBL2 CBX1 PRKAR2A DDX24 UTRN TOP2A EPB41L2 DNM2 | 3.57e-06 | 394 | 167 | 11 | 27248496 |
| Pubmed | CCPG1 ILF3 NOP16 FBL RPS6 BAZ1B EVPL RUVBL2 PABPC1 ARHGAP5 CRNKL1 EIF2S1 NUP210 DDX24 TOP2A MOV10 | 3.63e-06 | 847 | 167 | 16 | 35850772 | |
| Pubmed | 3.67e-06 | 187 | 167 | 8 | 26460568 | ||
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 9679146 | ||
| Pubmed | 3.75e-06 | 7 | 167 | 3 | 34143182 | ||
| Interaction | CHD3 interactions | SIN3B ILF3 SLC27A6 MTF2 DSP FBL RPS6 SPTBN1 RNF113A ACTB BAZ1B ACTG1 PABPC1 BPTF EIF2S1 CBX1 ASCC3 UROD ZBED1 DDX24 TOP2A EPB41L2 MOV10 MX1 PCNT | 2.84e-09 | 757 | 165 | 25 | int:CHD3 |
| Interaction | EED interactions | TPM3 ILF3 NAA15 NUP85 MTF2 DSP FBL USP9X RPS6 SPTBN1 ACTB OBSCN BAZ1B ACTG1 LRRC40 RUVBL2 GDI2 PABPC1 TTLL12 BPTF CRNKL1 IPO9 PXDN EIF2S1 CLK3 SNX7 NUP210 ZNF516 ASCC3 DDX24 TOP2A VPS29 MOV10 DNM2 PCNT | 5.09e-09 | 1445 | 165 | 35 | int:EED |
| Interaction | ACTG1 interactions | TPM3 ILF3 MYO9B POTEF SPTBN1 RNF113A ACTB ACTG1 RUVBL2 ADD1 ADD3 MYO5C TWF1 POTEE IPO9 UCHL5 PRKCA POTEI WDR44 SFN | 1.03e-08 | 520 | 165 | 20 | int:ACTG1 |
| Interaction | ACTA1 interactions | TPM2 TPM3 ILF3 MYO9B POTEF ACTB USP25 ACTG1 TTLL12 POTEE PRKCA POTEI UTRN EPB41L2 DNM2 SFN | 7.12e-08 | 371 | 165 | 16 | int:ACTA1 |
| Interaction | ACTB interactions | TPM2 TPM3 ILF3 MYO9B POTEF RPS6 SPTBN1 ACTB USP25 BAZ1B ACTG1 PSTPIP1 RUVBL2 GDI2 PABPC1 ADD1 ADD3 TWF1 POTEE IPO9 PLEKHG6 UCHL5 PRKCA POTEI DNM1 MX1 WDR44 | 2.17e-07 | 1083 | 165 | 27 | int:ACTB |
| Interaction | BAP1 interactions | TPM3 ILF3 NAA15 DSP MYO9B USP9X RPS6 SPTBN1 ACTB RBM26 E2F1 EXT1 RUVBL2 GDI2 PABPC1 ADD1 TTLL12 IPO9 EIF2S1 UCHL5 CBX1 PRKAR2A PRKCA ASCC3 OBI1 VPS29 EPB41L2 MOV10 DNM2 SFN | 2.79e-07 | 1314 | 165 | 30 | int:BAP1 |
| Interaction | KCTD13 interactions | TPM3 RALA DPP6 ILF3 DSP PACSIN1 USP9X SYNE1 RPS6 SPTBN1 ACTB USP25 POR ACTG1 SRCIN1 GDI2 PABPC1 ADD1 ADD3 TWF1 ARHGAP5 TENM4 EIF2S1 CRACDL PRKAR2A PRKCA DNM1 UTRN EPB41L2 DNM2 DNAH11 | 3.03e-07 | 1394 | 165 | 31 | int:KCTD13 |
| Interaction | FMR1 interactions | SIN3B ILF3 FBL USP9X RPS6 SPTBN1 RNF113A ACTB ARHGEF18 DAZL PABPC1 POTEE EIF2S1 DNM1 TOP2A PICK1 MOV10 PCNT | 4.40e-07 | 536 | 165 | 18 | int:FMR1 |
| Interaction | CCDC8 interactions | RALA ILF3 DSP MYO9B FBL USP9X BAZ1B ACTG1 LRRC40 RUVBL2 PABPC1 MYO5C EIF2S1 PRKCA ASCC3 UTRN CDH5 TOP2A EPB41L2 PCNT | 4.49e-07 | 656 | 165 | 20 | int:CCDC8 |
| Interaction | RGS14 interactions | TPM2 TPM3 ILF3 RPS6 SPTBN1 ACTG1 SRCIN1 ADD3 IPO9 EIF2S1 CRACDL PRKCA | 7.00e-07 | 240 | 165 | 12 | int:RGS14 |
| Interaction | SIRT7 interactions | NAA15 DSP FBL USP9X RPS6 SPTBN1 BAZ1B GDI2 PABPC1 TTLL12 BPTF CRNKL1 NUP210 ASCC3 DDX24 UTRN TOP2A EPB41L2 MOV10 DNM2 PCNT | 7.92e-07 | 744 | 165 | 21 | int:SIRT7 |
| Interaction | NDN interactions | ILF3 DSP FBL RPS6 ACTB E2F1 RUVBL2 GDI2 PABPC1 TTLL12 PPARGC1A IFFO2 ASCC3 DDX24 CDH5 TOP2A | 1.04e-06 | 453 | 165 | 16 | int:NDN |
| Interaction | BIRC3 interactions | TPM3 RALA ILF3 DSP FBL USP9X SYNE1 RPS6 SPTBN1 RBM26 POR BAZ1B ACTG1 E2F1 RUVBL2 GDI2 PABPC1 CRNKL1 IPO9 EIF2S1 SNX7 UCHL5 NUP210 PRKAR2A CHST2 ITM2B DDX24 TOP2A EPB41L2 | 1.24e-06 | 1334 | 165 | 29 | int:BIRC3 |
| Interaction | NAA40 interactions | TPM3 SYNRG SIN3B ILF3 NAA15 DSP RPS6 CDKN2AIP RNF113A ACTB RBM26 ANKRD26 BAZ1B PABPC1 ADD1 ADD3 TWF1 CBX1 UTRN TOP2A EPB41L2 WDR44 DNM2 PCNT | 1.47e-06 | 978 | 165 | 24 | int:NAA40 |
| Interaction | CDC5L interactions | CCZ1B ILF3 FOXP2 DSP SYNE1 RPS6 CDKN2AIP SPTBN1 RNF113A ACTB LRRC40 VPS36 RUVBL2 PABPC1 TWF1 CRNKL1 IPO9 CCZ1 UCHL5 TOP2A DNM2 PCNT | 1.96e-06 | 855 | 165 | 22 | int:CDC5L |
| Interaction | FBXW7 interactions | TPM2 TPM3 NAT8B NOP16 FOXP2 TRPM7 MYO9B FBL USP9X RPS6 SPTBN1 SREBF1 BAZ1B EXT1 RUVBL2 PPARGC1A IPO9 ARHGEF10 EIF2S1 PRKCA ASCC3 CDC34 DDX24 TOP2A MOV10 DNM2 SFN | 2.01e-06 | 1215 | 165 | 27 | int:FBXW7 |
| Interaction | LARP1B interactions | 2.19e-06 | 139 | 165 | 9 | int:LARP1B | |
| Interaction | YAP1 interactions | TPM2 SIN3B DSP FBL USP9X POTEF RPS6 SPTBN1 ACTB RBM26 BAZ1B ACTG1 RUVBL2 PABPC1 ADD1 ADD3 TWF1 POTEE BPTF PABPC3 DGCR8 POTEI EPB41L2 MOV10 SFN | 3.16e-06 | 1095 | 165 | 25 | int:YAP1 |
| Interaction | MEX3A interactions | TPM2 MYO9B USP9X RPS6 SPTBN1 BAZ1B DAZL PABPC1 LIF PXDN MRPL14 ARHGEF10 TOP2A MOV10 | 3.51e-06 | 384 | 165 | 14 | int:MEX3A |
| Interaction | MOV10 interactions | TPM3 ILF3 FBL RPS6 CLK4 RNF113A OBSCN E2F1 DAZL VPS36 ARFIP2 CREB3L4 PABPC1 CRNKL1 KANK1 LRRC42 CEP95 CLK3 MTR PRKCA DGCR8 ASCC3 UROD DDX24 OBI1 EPB41L2 MOV10 | 6.78e-06 | 1297 | 165 | 27 | int:MOV10 |
| Interaction | TMOD1 interactions | 7.33e-06 | 161 | 165 | 9 | int:TMOD1 | |
| Interaction | STIP1 interactions | ILF3 NAA15 NUP85 FBL USP9X SPTBN1 ACTB LRRC40 RUVBL2 GDI2 PABPC1 ADD1 ADD3 TTLL12 CRNKL1 IPO9 ARHGEF10 EIF2S1 NUP210 PRKAR2A ASCC3 EPB41L2 DNM2 | 8.00e-06 | 1006 | 165 | 23 | int:STIP1 |
| Interaction | ADD1 interactions | 1.19e-05 | 171 | 165 | 9 | int:ADD1 | |
| Interaction | ECT2 interactions | TPM2 CCDC91 TPM3 ILF3 DSP FBL USP9X RPS6 SPTBN1 OXCT2 POR VPS36 PABPC1 MYO5C RNF14 POTEE IPO9 PABPC3 NUP210 TOP2A MOV10 | 1.22e-05 | 887 | 165 | 21 | int:ECT2 |
| Interaction | ADARB1 interactions | SIN3B ILF3 NOP16 POTEF RPS6 ACTB RBM26 ACTG1 PSTPIP1 RUVBL2 BPTF POTEI DDX24 TOP2A MOV10 | 1.25e-05 | 489 | 165 | 15 | int:ADARB1 |
| Interaction | PIM3 interactions | 1.27e-05 | 63 | 165 | 6 | int:PIM3 | |
| Interaction | ISG15 interactions | TPM2 TPM3 ILF3 ACTB POR ACTG1 RUVBL2 GDI2 PABPC1 MYO5C UCHL5 ASCC3 TOP2A MX1 SFN | 1.41e-05 | 494 | 165 | 15 | int:ISG15 |
| Interaction | NPM1 interactions | FILIP1 ILF3 NAA15 NOP16 SLC27A6 DSP MYO9B FBL RPS6 RNF113A ACTB BAZ1B ACTG1 PABPC1 ARHGAP5 CRNKL1 IPO9 EIF2S1 PRKCA ASCC3 DDX24 UTRN TOP2A VPS29 MOV10 | 1.56e-05 | 1201 | 165 | 25 | int:NPM1 |
| Interaction | ACTC1 interactions | POTEF SYNE1 SPTBN1 RNF113A ACTB ACTG1 RUVBL2 PABPC1 ADD1 ADD3 MYO5C TWF1 POTEE CRNKL1 EIF2S1 UCHL5 POTEI UTRN | 1.62e-05 | 694 | 165 | 18 | int:ACTC1 |
| Interaction | NAP1L2 interactions | 1.81e-05 | 40 | 165 | 5 | int:NAP1L2 | |
| Interaction | PFN1 interactions | SYNRG MYO9B SPTBN1 ACTB ANKRD26 ACTG1 MYO5C ARHGAP5 UCHL5 MTR PRKAR2A DNM1 WDR44 DNM2 PCNT | 1.99e-05 | 509 | 165 | 15 | int:PFN1 |
| Interaction | DYNLL1 interactions | ILF3 DSP ACTB CCDC18 ACTG1 PABPC1 KANK1 IFFO2 DNM3 MTR CBX1 PRKAR2A EPB41L2 DNM2 PCNT | 2.04e-05 | 510 | 165 | 15 | int:DYNLL1 |
| Interaction | CDKN2A interactions | FBL CDKN2AIP ACTB RBM26 ACTG1 E2F1 ARFIP2 RUVBL2 MTR PRKCA DGCR8 MOV10 | 2.13e-05 | 335 | 165 | 12 | int:CDKN2A |
| Interaction | XRCC6 interactions | ILF3 NAA15 FBL RPS6 CDKN2AIP SPTBN1 RNF113A RBM26 POR BAZ1B SERPINA2 RUVBL2 GDI2 BPTF ARHGAP5 EIF2S1 CBX1 DGCR8 TOP2A MOV10 DNM2 | 2.39e-05 | 928 | 165 | 21 | int:XRCC6 |
| Interaction | CTNNB1 interactions | TPM3 ILF3 NAA15 USP9X RPS6 ACTB ANKRD26 ACTG1 SRCIN1 RUVBL2 PABPC1 RNF14 ARHGAP5 EIF2S1 UCHL5 PRKCA UTRN CDH5 TOP2A PICK1 MOV10 SFN | 2.66e-05 | 1009 | 165 | 22 | int:CTNNB1 |
| Interaction | STAU2 interactions | 2.66e-05 | 237 | 165 | 10 | int:STAU2 | |
| Interaction | CDC42 interactions | RALA NAA15 NUP85 TRPM7 DSP MYO9B FBL USP9X SYNE1 RPS6 SPTBN1 ACTB ANKRD26 POR ADD3 ARHGAP5 IPO9 PXDN TENM3 ARHGEF10 CLK3 NUP210 LRP2 PRKCA UTRN PICK1 | 2.78e-05 | 1323 | 165 | 26 | int:CDC42 |
| Interaction | CHD4 interactions | ILF3 MTF2 DSP FBL RPS6 RNF113A ACTB BAZ1B PSTPIP1 RUVBL2 PABPC1 RNF14 BPTF CRNKL1 EIF2S1 CBX1 PRKAR2A CDC34 DDX24 TOP2A PCNT | 2.80e-05 | 938 | 165 | 21 | int:CHD4 |
| Interaction | RPS2 interactions | ILF3 FBL RPS6 SPTBN1 RNF113A ACTB USP25 BAZ1B ACTG1 RUVBL2 PABPC1 ASCC3 DDX24 TOP2A MOV10 DNM2 SFN | 2.91e-05 | 657 | 165 | 17 | int:RPS2 |
| Interaction | LARP1 interactions | ILF3 FBL RPS6 SPTBN1 RNF113A PABPC1 IPO9 CLK3 UCHL5 DGCR8 CDC34 MOV10 WDR44 SFN | 3.01e-05 | 465 | 165 | 14 | int:LARP1 |
| Interaction | BMI1 interactions | TPM2 ILF3 MTF2 FBL SYNE1 SPTBN1 BAZ1B ACTG1 EVPL RUVBL2 POTEE CRNKL1 PABPC3 DGCR8 TOP2A MOV10 SFN | 3.02e-05 | 659 | 165 | 17 | int:BMI1 |
| Interaction | PCNT interactions | 3.07e-05 | 241 | 165 | 10 | int:PCNT | |
| Interaction | REPIN1 interactions | 3.21e-05 | 109 | 165 | 7 | int:REPIN1 | |
| Interaction | PRKCA interactions | DSP ACTB ACTG1 ADD1 ADD3 EIF2S1 PRKAR2A PRKCA DNM1 CDH5 TOP2A PICK1 MOV10 | 3.27e-05 | 408 | 165 | 13 | int:PRKCA |
| Interaction | PPP1CB interactions | TPM2 TPM3 ILF3 SPTBN1 ACTB ACTG1 MYO5C TWF1 UCHL5 PRKAR2A UXT CDC34 DDX24 WDR44 | 3.31e-05 | 469 | 165 | 14 | int:PPP1CB |
| Interaction | AGO2 interactions | ILF3 TRPM7 FBL POTEF CDKN2AIP RNF113A ACTB DAZL RUVBL2 PABPC1 CDC34 OBI1 MOV10 DNM2 | 3.55e-05 | 472 | 165 | 14 | int:AGO2 |
| Interaction | EAPP interactions | 3.74e-05 | 76 | 165 | 6 | int:EAPP | |
| Interaction | RNF8 interactions | TPM3 DSP FBL SPTBN1 ACTB RUVBL2 PABPC1 EIF2S1 CLK3 DGCR8 PICK1 DNM2 SFN | 4.51e-05 | 421 | 165 | 13 | int:RNF8 |
| Interaction | CAPZB interactions | TPM2 TPM3 RPS6 SPTBN1 RNF113A ACTB ACTG1 ARHGEF18 RUVBL2 PABPC1 MYO5C TWF1 CRNKL1 CCZ1 EIF2S1 UCHL5 CRACDL DDX24 OBI1 TOP2A VPS29 DNM2 | 4.76e-05 | 1049 | 165 | 22 | int:CAPZB |
| Interaction | AKAP13 interactions | 4.79e-05 | 116 | 165 | 7 | int:AKAP13 | |
| Interaction | DNM1 interactions | 4.84e-05 | 158 | 165 | 8 | int:DNM1 | |
| Interaction | NUDCD2 interactions | CCDC60 ILF3 DSP USP9X SYNE1 RPS6 CDKN2AIP SPTBN1 ACTB OBSCN PABPC1 NUP210 ABCB11 | 4.85e-05 | 424 | 165 | 13 | int:NUDCD2 |
| Interaction | ACTG2 interactions | 4.93e-05 | 49 | 165 | 5 | int:ACTG2 | |
| Interaction | CHMP4C interactions | ILF3 DSP FBL RPS6 SPTBN1 POR BAZ1B RUVBL2 GDI2 PABPC1 EIF2S1 UCHL5 PABPC3 NUP210 TOP2A MOV10 SFN | 5.07e-05 | 687 | 165 | 17 | int:CHMP4C |
| Interaction | PAFAH1B1 interactions | 5.46e-05 | 258 | 165 | 10 | int:PAFAH1B1 | |
| Interaction | SFN interactions | SYNRG TRPM7 RPS6 SPTBN1 CCDC18 ANKRD26 ACTG1 RUVBL2 PABPC1 IPO9 ARHGEF10 EIF2S1 CEP95 DDX24 OBI1 EPB41L2 SFN | 5.55e-05 | 692 | 165 | 17 | int:SFN |
| Interaction | TNIP1 interactions | TPM2 TPM3 ILF3 NOP16 DSP FBL POTEF SYNE1 RPS6 SPTBN1 ACTB ACTG1 PABPC1 MYO5C TWF1 ARHGAP5 CRNKL1 PXDN MRPL14 TENM3 EIF2S1 CLK3 TOP2A MOV10 | 5.56e-05 | 1217 | 165 | 24 | int:TNIP1 |
| Interaction | TPM4 interactions | 5.64e-05 | 259 | 165 | 10 | int:TPM4 | |
| Interaction | TMOD2 interactions | 5.76e-05 | 82 | 165 | 6 | int:TMOD2 | |
| Interaction | AGAP2 interactions | 6.01e-05 | 210 | 165 | 9 | int:AGAP2 | |
| Interaction | NDEL1 interactions | 6.30e-05 | 164 | 165 | 8 | int:NDEL1 | |
| Interaction | SLFN11 interactions | FILIP1 CCPG1 NUP85 POTEF SREBF1 ACTG1 RUVBL2 POTEE BPTF NUP210 TOP2A MOV10 | 6.52e-05 | 376 | 165 | 12 | int:SLFN11 |
| Interaction | POTEJ interactions | 6.59e-05 | 52 | 165 | 5 | int:POTEJ | |
| Interaction | PLEKHG6 interactions | 7.23e-05 | 53 | 165 | 5 | int:PLEKHG6 | |
| Interaction | MYO5C interactions | 7.47e-05 | 168 | 165 | 8 | int:MYO5C | |
| Interaction | MAP4 interactions | TPM3 ILF3 DSP RNF113A ACTB RUVBL2 PABPC1 EIF2S1 UCHL5 CBX1 SFN | 7.65e-05 | 324 | 165 | 11 | int:MAP4 |
| Interaction | MEPCE interactions | ILF3 NOP16 FBL POTEF RPS6 RNF113A ACTB ACTG1 LRRC40 RUVBL2 PABPC1 POTEE IPO9 CLK3 PABPC3 POTEI EPB41L2 MOV10 DNM2 | 8.13e-05 | 859 | 165 | 19 | int:MEPCE |
| Interaction | IFI16 interactions | ILF3 NUP85 NOP16 SYNE1 ACTB OBSCN BAZ1B RUVBL2 PABPC1 ADD1 CRNKL1 CBX1 ASCC3 DDX24 OBI1 TOP2A MOV10 | 8.14e-05 | 714 | 165 | 17 | int:IFI16 |
| Interaction | MKRN2 interactions | FOXP2 ANKRD26 E2F1 DAZL EXT1 PABPC1 TENM3 PRKCA ASCC3 TOP2A MOV10 PCNT | 8.16e-05 | 385 | 165 | 12 | int:MKRN2 |
| Interaction | FBXO32 interactions | DSP ACTB ACTG1 TTLL12 CRNKL1 IPO9 UCHL5 ASCC3 CDC34 DDX24 TOP2A DNM2 | 8.36e-05 | 386 | 165 | 12 | int:FBXO32 |
| Interaction | INSIG1 interactions | 8.52e-05 | 127 | 165 | 7 | int:INSIG1 | |
| Interaction | SRPK2 interactions | ILF3 NOP16 FBL RPS6 RNF113A ACTB RBM26 ACTG1 PABPC1 OTOF CLK3 DGCR8 DDX24 OBI1 TOP2A EPB41L2 MOV10 | 8.56e-05 | 717 | 165 | 17 | int:SRPK2 |
| Interaction | MAPRE1 interactions | NUP85 CENPE RPS6 SPTBN1 ANKRD26 BAZ1B PABPC1 ADD1 ADD3 NUP210 CBX1 PRKAR2A PRKCA PCNT | 8.84e-05 | 514 | 165 | 14 | int:MAPRE1 |
| Interaction | BIN1 interactions | 9.40e-05 | 129 | 165 | 7 | int:BIN1 | |
| Interaction | MRFAP1 interactions | 1.03e-04 | 91 | 165 | 6 | int:MRFAP1 | |
| Interaction | RAD18 interactions | TPM3 RPS6 SPTBN1 ACTB RBM26 BAZ1B RUVBL2 TWF1 BPTF CLK3 UTRN TOP2A EPB41L2 | 1.03e-04 | 457 | 165 | 13 | int:RAD18 |
| Interaction | ZC3H18 interactions | ILF3 NOP16 DSP FBL RPS6 CLK4 SPTBN1 RNF113A ACTG1 RUVBL2 CRNKL1 MRPL14 EIF2S1 CLK3 DDX24 TOP2A EPB41L2 MOV10 SFN | 1.07e-04 | 877 | 165 | 19 | int:ZC3H18 |
| Interaction | IQGAP1 interactions | TPM2 TPM3 ILF3 RPS6 SPTBN1 RNF113A ACTB ACTG1 RUVBL2 PABPC1 ADD1 MYO5C TWF1 PPARGC1A ASCC3 | 1.08e-04 | 591 | 165 | 15 | int:IQGAP1 |
| Interaction | MGMT interactions | 1.10e-04 | 92 | 165 | 6 | int:MGMT | |
| Interaction | SCIN interactions | 1.12e-04 | 58 | 165 | 5 | int:SCIN | |
| Interaction | DUXA interactions | 1.12e-04 | 12 | 165 | 3 | int:DUXA | |
| Interaction | TERF2 interactions | FBL USP9X SYNE1 RPS6 RNF113A POTEE AFAP1L2 CLK3 DDX24 UTRN TOP2A | 1.17e-04 | 340 | 165 | 11 | int:TERF2 |
| Interaction | RHOA interactions | RALA NUP85 TRPM7 MYO9B FBL USP9X SPTBN1 ANKRD26 POR ARHGEF18 ADD3 ARHGAP5 IPO9 PLEKHG6 TENM3 ARHGEF10 CLK3 NUP210 LRP2 PRKCA CDC34 UTRN DNM2 | 1.22e-04 | 1199 | 165 | 23 | int:RHOA |
| Interaction | MAPT interactions | TPM3 SYNRG ILF3 PACSIN1 RPS6 ACTB ACTG1 SRCIN1 RUVBL2 GDI2 PABPC1 ADD1 ADD3 MRPL14 EIF2S1 DGUOK PRKAR2A PRKCA DGCR8 DNM1 DNM2 SFN | 1.22e-04 | 1119 | 165 | 22 | int:MAPT |
| Interaction | PACSIN1 interactions | 1.31e-04 | 60 | 165 | 5 | int:PACSIN1 | |
| Interaction | RHOF interactions | RALA TRPM7 MYO9B FBL USP9X SPTBN1 ACTB ANKRD26 POR ADD1 ADD3 POTEE ARHGAP5 PRKAR2A UTRN MOV10 | 1.35e-04 | 673 | 165 | 16 | int:RHOF |
| Interaction | NIP7 interactions | 1.35e-04 | 183 | 165 | 8 | int:NIP7 | |
| Interaction | SMARCA2 interactions | TPM3 SIN3B ACTB SREBF1 BAZ1B ACTG1 E2F1 ZKSCAN2 CBX1 PICK1 DNM2 | 1.37e-04 | 346 | 165 | 11 | int:SMARCA2 |
| Interaction | CTNNA1 interactions | SPTBN1 ACTB RBM26 ANKRD26 ACTG1 SRCIN1 IPO9 UTRN CDH5 OBI1 EPB41L2 | 1.40e-04 | 347 | 165 | 11 | int:CTNNA1 |
| Interaction | PRC1 interactions | ILF3 NUP85 NOP16 CENPE DSP FBL SYNE1 RPS6 SPTBN1 POR BAZ1B RUVBL2 PABPC1 PABPC3 CRACDL NUP210 CEP83 CBX1 TOP2A EPB41L2 | 1.41e-04 | 973 | 165 | 20 | int:PRC1 |
| Interaction | SMG1 interactions | 1.47e-04 | 97 | 165 | 6 | int:SMG1 | |
| Interaction | KPNA1 interactions | ILF3 FBL USP9X CDKN2AIP CLK4 BAZ1B RUVBL2 BPTF CLK3 CDC34 TOP2A | 1.55e-04 | 351 | 165 | 11 | int:KPNA1 |
| Interaction | ELAVL2 interactions | 1.63e-04 | 188 | 165 | 8 | int:ELAVL2 | |
| Interaction | HECTD1 interactions | TPM2 CENPE MYO9B FBL USP9X SREBF1 BAZ1B RUVBL2 MYO5C BPTF ARHGEF10 EIF2S1 DNM3 DGCR8 ASCC3 DDX24 UTRN TOP2A MOV10 SFN | 1.64e-04 | 984 | 165 | 20 | int:HECTD1 |
| Interaction | RAC1 interactions | TRPM7 USP9X RPS6 SPTBN1 ACTB ANKRD26 POR ARFIP2 PABPC1 ADD1 ADD3 ARHGAP5 PLEKHG6 ARHGEF10 LRP2 PRKAR2A PRKCA CDC34 UTRN TOP2A PICK1 | 1.65e-04 | 1063 | 165 | 21 | int:RAC1 |
| Interaction | G3BP1 interactions | TPM2 DSP FBL SYNE1 RPS6 RNF113A ACTB RBM26 DAZL PABPC1 ADD3 NUP210 CBX1 ASCC3 CDC34 TOP2A MOV10 SFN | 1.74e-04 | 835 | 165 | 18 | int:G3BP1 |
| Interaction | SYNPO interactions | 1.88e-04 | 192 | 165 | 8 | int:SYNPO | |
| Interaction | GATAD2B interactions | 1.94e-04 | 245 | 165 | 9 | int:GATAD2B | |
| Interaction | PAIP1 interactions | 2.03e-04 | 146 | 165 | 7 | int:PAIP1 | |
| Interaction | CAP2 interactions | 2.07e-04 | 66 | 165 | 5 | int:CAP2 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | RASA2 SPTBN1 VEPH1 ARHGEF18 AFAP1L2 PLEKHG6 DNM3 DNM1 DNM2 PHLPP2 | 9.92e-07 | 206 | 118 | 10 | 682 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 7.39e-05 | 13 | 118 | 3 | 685 | |
| GeneFamily | Tropomyosins | 2.51e-04 | 4 | 118 | 2 | 777 | |
| GeneFamily | CDC like kinases | 2.51e-04 | 4 | 118 | 2 | 480 | |
| GeneFamily | Actins | 6.23e-04 | 6 | 118 | 2 | 929 | |
| GeneFamily | RAS type GTPase family | 1.07e-03 | 31 | 118 | 3 | 389 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.15e-03 | 8 | 118 | 2 | 939 | |
| GeneFamily | Classical BAR domain containing | 1.15e-03 | 8 | 118 | 2 | 1292 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | RASA2 CENPE MYO9B SPTBN1 ARFIP2 ARHGAP5 UXT TOP2A EPB41L2 PCNT | 5.71e-07 | 199 | 165 | 10 | M5893 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CCDC91 RALA NAA15 CENPE USP9X RBM26 USP25 BAZ1B LRRC40 EXT1 ADD3 BPTF ARHGAP5 PPARGC1A UCHL5 MTR OBI1 | 9.27e-07 | 656 | 165 | 17 | M18979 |
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 1.44e-06 | 14 | 165 | 4 | M2442 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | ILF3 NAA15 CENPE MTF2 FBL E2F1 PABPC1 ADD3 ARHGAP5 EIF2S1 UCHL5 NUP210 IFFO2 CBX1 TOP2A | 2.51e-06 | 555 | 165 | 15 | M2343 |
| Coexpression | RAHMAN_TP53_TARGETS_PHOSPHORYLATED | 6.78e-06 | 20 | 165 | 4 | M1333 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | SYNRG RASA2 FBL SYNE1 RPS6 CDKN2AIP CLK4 SPTBN1 PABPC1 TGFBR3 BPTF ARHGAP5 CEP95 IFFO2 PRKCA UXT ABCD2 PHLPP2 BRWD1 | 2.20e-05 | 1012 | 165 | 19 | M40864 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | TPM3 CENPE DSP SPTBN1 ACTG1 PABPC1 ADD3 MYO5C MRPL14 TOP2A DNM2 SFN | 3.56e-05 | 458 | 165 | 12 | M40010 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 4.12e-05 | 200 | 165 | 8 | M3635 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | CCZ1B NAA15 NUP85 NOP16 CENPE CDKN2AIP CCDC18 ANKRD26 BAZ1B E2F1 LRRC40 RUVBL2 LRRC42 IPO9 EIF2S1 UCHL5 NUP210 CBX1 TOP2A EPB41L2 MOV10 PCNT | 4.79e-05 | 1363 | 165 | 22 | M45782 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 5.19e-05 | 152 | 165 | 7 | M39243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 5.44e-05 | 208 | 165 | 8 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.21e-05 | 212 | 165 | 8 | M39221 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | SPTBN1 ODAD4 LYSMD3 RUVBL2 ADD3 KANK1 AFAP1L2 ARHGEF10 EIF2S1 AACS PRKCA DGCR8 TOP2A MOV10 | 6.29e-05 | 646 | 165 | 14 | M2419 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPM3 SYNRG RASA2 MYO9B USP9X SYNE1 ACTB RBM26 USP25 BAZ1B GIMAP7 PSTPIP1 ADD1 TGFBR3 BPTF NUP210 MTR GPCPD1 ASCC3 ITM2B DDX24 UTRN BRWD1 | 6.41e-05 | 1492 | 165 | 23 | M40023 |
| Coexpression | BENPORATH_SOX2_TARGETS | TPM3 ILF3 MTF2 USP25 CREB3L4 GRHL2 ADD3 RNF14 KANK1 CEP95 ZNF516 LRP2 OBI1 TOP2A DNM2 | 6.62e-05 | 734 | 165 | 15 | M3835 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN CCPG1 FOXP2 SYNE1 SPTBN1 ACTB SRCIN1 ADD3 TGFBR3 ARHGAP5 KIRREL3 KANK1 LRRC42 PXDN CEP95 DNM3 PRKAR2A PRKCA EPB41L2 | 6.92e-05 | 1102 | 165 | 19 | M2369 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 7.32e-05 | 217 | 165 | 8 | M16407 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CCDC91 CCZ1B MTF2 USP9X SPTBN1 LRRC40 RUVBL2 ADD1 ADD3 TWF1 RNF14 CCZ1 EIF2S1 DGUOK NUP210 AACS MTR CBX1 PRKCA ASCC3 | 8.32e-05 | 1215 | 165 | 20 | M41122 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN CCPG1 FOXP2 SYNE1 SPTBN1 ACTB SRCIN1 ADD3 TGFBR3 ARHGAP5 KIRREL3 KANK1 LRRC42 PXDN CEP95 DNM3 PRKAR2A PRKCA EPB41L2 | 8.97e-05 | 1124 | 165 | 19 | MM1070 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | SPTBN1 ODAD4 LYSMD3 RUVBL2 ADD3 KANK1 AFAP1L2 ARHGEF10 EIF2S1 AACS PRKCA DGCR8 TOP2A MOV10 | 1.00e-04 | 675 | 165 | 14 | MM1073 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.03e-04 | 228 | 165 | 8 | MM1014 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RALA CENPE MTF2 MYO9B USP9X BAZ1B EXT1 TGFBR3 BPTF ARHGEF10 MTR PRKCA ASCC3 TOP2A PHLPP2 PCNT | 1.07e-04 | 856 | 165 | 16 | M4500 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | DPP6 USP9X ACTG1 ARHGEF18 ADD3 TGFBR3 ARHGAP5 KANK1 ZNF516 CHST2 PHLPP2 | 1.08e-04 | 437 | 165 | 11 | M4665 |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 1.09e-04 | 171 | 165 | 7 | M7105 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.20e-04 | 233 | 165 | 8 | M13273 | |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP | 1.27e-04 | 77 | 165 | 5 | M1992 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.35e-04 | 177 | 165 | 7 | M39245 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 1.44e-04 | 125 | 165 | 6 | M38988 | |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN | 1.45e-04 | 179 | 165 | 7 | M6324 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CCPG1 NAA15 FBL CCDC18 ACTG1 LYSMD3 CREB3L4 GDI2 PABPC1 ADD1 LIF LRRC42 PLEKHG6 EIF2S1 PABPC3 CRACDL ITM2B DDX24 MOV10 WDR44 | 1.62e-04 | 1277 | 165 | 20 | MM1032 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | ILF3 SPTBN1 ACTG1 EXT1 ADD3 PXDN SNX7 PRKCA CHST2 DNM1 EPB41L2 | 1.85e-04 | 465 | 165 | 11 | M9192 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.94e-04 | 250 | 165 | 8 | M11318 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_UP | 1.95e-04 | 318 | 165 | 9 | M11171 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ILF3 NAA15 NUP85 NOP16 CENPE TRPM7 MTF2 FBL CCDC18 BAZ1B E2F1 LRRC40 EXT1 IPO9 CCZ1 ARHGEF10 UCHL5 MTR CBX1 ASCC3 TOP2A | 2.13e-04 | 1407 | 165 | 21 | M14427 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 2.15e-04 | 86 | 165 | 5 | M39248 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | TPM3 SYNRG MYO9B SYNE1 RPS6 ACTB RBM26 ACTG1 GIMAP7 PSTPIP1 ADD1 BPTF NUP210 ITM2B DDX24 UTRN | 2.16e-04 | 911 | 165 | 16 | M40038 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.44e-04 | 195 | 165 | 7 | M13736 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP | 2.52e-04 | 196 | 165 | 7 | M7666 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 2.60e-04 | 197 | 165 | 7 | M8464 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.60e-04 | 197 | 165 | 7 | M5480 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.66e-04 | 90 | 165 | 5 | M39250 | |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP | 2.77e-04 | 199 | 165 | 7 | M8000 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 2.77e-04 | 199 | 165 | 7 | M8371 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_DN | 2.77e-04 | 199 | 165 | 7 | M9574 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 2.77e-04 | 199 | 165 | 7 | M7451 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 2.77e-04 | 199 | 165 | 7 | M8770 | |
| Coexpression | GSE14308_TH2_VS_TH17_UP | 2.85e-04 | 200 | 165 | 7 | M3361 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M8204 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN | 2.85e-04 | 200 | 165 | 7 | M3975 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M7502 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN | 2.85e-04 | 200 | 165 | 7 | M3851 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_UP | 2.85e-04 | 200 | 165 | 7 | M6390 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN | 2.85e-04 | 200 | 165 | 7 | M6408 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP | 2.85e-04 | 200 | 165 | 7 | M7594 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 2.85e-04 | 200 | 165 | 7 | M6671 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 2.85e-04 | 200 | 165 | 7 | M5261 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 2.85e-04 | 200 | 165 | 7 | M6745 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M9136 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP | 2.85e-04 | 200 | 165 | 7 | M4351 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | TPM2 RALA SIN3B RASA2 ACTB POR DNAJC18 ACTG1 E2F1 EXT1 VPS36 PSTPIP1 MYO5C PXDN UCHL5 PRKAR2A PRKCA PICK1 | 3.05e-04 | 1136 | 165 | 18 | M2247 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CCPG1 NAA15 FBL CCDC18 ACTG1 LYSMD3 CREB3L4 GDI2 PABPC1 ADD1 LIF LRRC42 PLEKHG6 EIF2S1 CRACDL ITM2B DDX24 MOV10 WDR44 | 3.11e-04 | 1239 | 165 | 19 | M1743 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 3.21e-04 | 145 | 165 | 6 | M3045 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RALB CCPG1 RASA2 FOXP2 DSP USP9X USP25 ARHGEF18 LYSMD3 TGFBR3 ARHGAP5 KANK1 AFAP1L2 PRKCA CDH5 | 3.42e-04 | 854 | 165 | 15 | M1533 |
| Coexpression | KAAB_FAILED_HEART_ATRIUM_DN | 3.46e-04 | 147 | 165 | 6 | M10619 | |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 3.49e-04 | 53 | 165 | 4 | M17537 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RALA CCZ1B ILF3 FBL RNF113A BAZ1B VPS36 PDPK2P GDI2 IPO9 MRPL14 CCZ1 EIF2S1 CBX1 PRKAR2A UROD CDC34 VPS29 | 3.84e-04 | 1158 | 165 | 18 | MM1338 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | SPTBN1 EXT1 GIMAP7 GDI2 ADD3 ARHGAP5 ARHGEF10 ITM2B UTRN TET3 OBI1 | 3.87e-04 | 507 | 165 | 11 | MM1030 |
| Coexpression | LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB | 3.96e-04 | 278 | 165 | 8 | M39227 | |
| Coexpression | MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER | 4.02e-04 | 55 | 165 | 4 | M1065 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NAA15 FOXP2 CENPE TRPM7 MTF2 SPTBN1 ACTB RBM26 USP25 ANKRD26 DAZL LYSMD3 ADD1 TENM4 UCHL5 CBX1 UTRN OBI1 TOP2A EPB41L2 | 5.09e-06 | 815 | 164 | 20 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | ASZ1 CENPE MTF2 SPTBN1 RBM26 ANKRD26 DAZL LYSMD3 ADD1 TENM4 UCHL5 UTRN EPB41L2 | 1.84e-05 | 409 | 164 | 13 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.51e-05 | 75 | 164 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NAA15 ASZ1 MTF2 SPTBN1 RBM26 CCDC18 ANKRD26 DAZL LYSMD3 ADD1 ADD3 ARHGAP5 UCHL5 MTR UTRN EPB41L2 WDR44 MAJIN | 3.28e-05 | 776 | 164 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ILF3 USP9X BAZ1B GRHL2 PABPC1 BPTF PPARGC1A KANK1 GPCPD1 ASCC3 UTRN BRWD1 | 4.04e-05 | 379 | 164 | 12 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | CENPE TRPM7 SPTBN1 USP25 ANKRD26 LYSMD3 TENM4 UCHL5 UTRN OBI1 EPB41L2 | 4.43e-05 | 323 | 164 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NAA15 ASZ1 CENPE TRPM7 MTF2 EPYC SPTBN1 RBM26 DAZL LYSMD3 ADD1 PPARGC1A TENM4 UCHL5 MTR UTRN TOP2A EPB41L2 | 5.37e-05 | 806 | 164 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | ILF3 NAA15 CENPE TRPM7 USP9X BAZ1B PPARGC1A EIF2S1 IFFO2 GPCPD1 ASCC3 | 6.84e-05 | 339 | 164 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | NAA15 ASZ1 CENPE TRPM7 MTF2 RBM26 DAZL ADD1 TENM4 MTR UTRN EPB41L2 | 7.27e-05 | 403 | 164 | 12 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | NAA15 ASZ1 TRPM7 SPTBN1 RBM26 DAZL LYSMD3 ADD1 ADD3 ARHGAP5 TENM4 UCHL5 GPCPD1 UTRN EPB41L2 WDR44 RASD2 | 1.14e-04 | 778 | 164 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | RELN ILF3 USP9X BAZ1B GRHL2 PABPC1 SLC2A2 MYO5C BPTF PPARGC1A KANK1 LRP2 GPCPD1 ASCC3 UTRN DNM2 BRWD1 | 1.47e-04 | 795 | 164 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | ILF3 NAA15 CENPE TRPM7 USP9X VEPH1 BAZ1B GRHL2 PABPC1 SLC2A2 MYO5C PPARGC1A EIF2S1 NUP210 IFFO2 GPCPD1 ASCC3 | 1.61e-04 | 801 | 164 | 17 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.83e-04 | 152 | 164 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | SIN3B RELN ILF3 NUP85 USP9X SPTBN1 ACTB BAZ1B GRHL2 SLC2A2 PPARGC1A TENM4 NUP210 LRP2 GPCPD1 CBX1 CHST2 | 1.86e-04 | 811 | 164 | 17 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.60e-04 | 161 | 164 | 7 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k4 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-08 | 189 | 167 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.80e-07 | 171 | 167 | 8 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-07 | 178 | 167 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-07 | 178 | 167 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-07 | 179 | 167 | 8 | 2832a9ea1c84b809f4bb5fb39d7ad50af4b33fa9 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.96e-07 | 179 | 167 | 8 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 6.74e-07 | 192 | 167 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 7.01e-07 | 193 | 167 | 8 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.58e-07 | 195 | 167 | 8 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-07 | 197 | 167 | 8 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 8.83e-07 | 199 | 167 | 8 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.17e-07 | 200 | 167 | 8 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 9.17e-07 | 200 | 167 | 8 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.92e-06 | 154 | 167 | 7 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 158 | 167 | 7 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 158 | 167 | 7 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 4.15e-06 | 173 | 167 | 7 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 177 | 167 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.01e-06 | 183 | 167 | 7 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 185 | 167 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 185 | 167 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.68e-06 | 186 | 167 | 7 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.68e-06 | 186 | 167 | 7 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.68e-06 | 186 | 167 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-06 | 187 | 167 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.17e-06 | 188 | 167 | 7 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 7.17e-06 | 188 | 167 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.42e-06 | 189 | 167 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.68e-06 | 190 | 167 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 7.95e-06 | 191 | 167 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.22e-06 | 192 | 167 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 8.22e-06 | 192 | 167 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-06 | 193 | 167 | 7 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.50e-06 | 193 | 167 | 7 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-06 | 193 | 167 | 7 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.50e-06 | 193 | 167 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.50e-06 | 193 | 167 | 7 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 8.80e-06 | 194 | 167 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 195 | 167 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.09e-06 | 195 | 167 | 7 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.09e-06 | 195 | 167 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-06 | 196 | 167 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | normal_Lymph_Node-T/NK_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 9.72e-06 | 197 | 167 | 7 | 9d2dbf86e67d498e058e00bd1af73e16306dda0b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.72e-06 | 197 | 167 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.00e-05 | 198 | 167 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-05 | 198 | 167 | 7 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-05 | 198 | 167 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-05 | 198 | 167 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-05 | 199 | 167 | 7 | 9364199c5b4540ce2e14341fd9d504b695f8249d | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|lymphoid / Lineage, cell class and subclass | 1.04e-05 | 199 | 167 | 7 | 22926327c93ede9f3408c99a0d56e373a33240ef | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-05 | 199 | 167 | 7 | 5f67ea58512856cbdcef759088a5869720a947a8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 199 | 167 | 7 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 167 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | mLN-T_cell-Tcm|T_cell / Region, Cell class and subclass | 1.04e-05 | 199 | 167 | 7 | 75d4f23a5e5d4585ebdcc1cce057cf6bb9a920fd | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|World / Lineage, cell class and subclass | 1.04e-05 | 199 | 167 | 7 | 4de81f29c4d79868fd6254ceb81b4ddad22ae7d0 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC2|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.04e-05 | 199 | 167 | 7 | 829ec877c6c16c4abf8d3d139aea94af599406fe | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 200 | 167 | 7 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 200 | 167 | 7 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Sigmoid-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.07e-05 | 200 | 167 | 7 | 9c21e6b8d4f8e526950adacf9cc45a5e86d81c1f | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-05 | 200 | 167 | 7 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 1.07e-05 | 200 | 167 | 7 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 1.26e-05 | 136 | 167 | 6 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.28e-05 | 151 | 167 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 98 | 167 | 5 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 3.75e-05 | 165 | 167 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 4.15e-05 | 168 | 167 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.15e-05 | 168 | 167 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 4.29e-05 | 169 | 167 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.89e-05 | 173 | 167 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.05e-05 | 174 | 167 | 6 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 175 | 167 | 6 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 176 | 167 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-05 | 177 | 167 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-05 | 178 | 167 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-05 | 178 | 167 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 178 | 167 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.91e-05 | 179 | 167 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-05 | 179 | 167 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 179 | 167 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.09e-05 | 180 | 167 | 6 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 180 | 167 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-05 | 180 | 167 | 6 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 180 | 167 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 180 | 167 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-05 | 180 | 167 | 6 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 6.09e-05 | 180 | 167 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-05 | 181 | 167 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| Drug | AC1NST48 | SYNRG EPYC MYO9B FBL ACTB SREBF1 ACTG1 EVPL ARFIP2 CREB3L4 SLC2A2 TGFBR3 EIF2S1 DNM3 PRKAR2A PRKCA DNM1 ABCD2 DNM2 | 6.14e-08 | 594 | 164 | 19 | CID005315496 |
| Drug | plakin | 1.38e-07 | 82 | 164 | 8 | CID000018752 | |
| Drug | Cocaine | GABRB2 TPM3 NAA15 DSP USP9X SYNE1 CLK4 SPTBN1 RBM26 OBSCN PABPC1 RNF14 ARHGAP5 KIRREL3 PRODH2 TENM4 TENM3 CCZ1 EIF2S1 AACS DNM3 PRKCA DNM1 DNM2 PHLPP2 | 8.19e-06 | 1314 | 164 | 25 | ctd:D003042 |
| Drug | AC1Q6S1Y | 1.05e-05 | 104 | 164 | 7 | CID000122035 | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.19e-05 | 194 | 164 | 9 | 7406_DN | |
| Drug | Homocysteine | 1.24e-05 | 195 | 164 | 9 | ctd:D006710 | |
| Drug | AC1OAGGW | 1.71e-05 | 203 | 164 | 9 | CID006857364 | |
| Drug | 2gzl | 1.97e-05 | 46 | 164 | 5 | CID006102719 | |
| Drug | Lindane | GABRB2 TPM3 RALA RPS6 CDKN2AIP ACTB SREBF1 POR PABPC1 ADD3 LIF PPARGC1A SULT2A1 | 2.06e-05 | 443 | 164 | 13 | ctd:D001556 |
| Drug | Methamphetamine | OVCH2 DSP PACSIN1 SYNE1 RPS6 RNF113A ACTB OBSCN BAZ1B ACTG1 TTLL12 PPARGC1A SULT2A1 ARHGEF10 EIF2S1 CEP95 CBX1 DNM1 UTRN TOP2A VPS29 PICK1 MOV10 PCNT BRWD1 | 2.42e-05 | 1401 | 164 | 25 | ctd:D008694 |
| Drug | TCNB | 2.52e-05 | 119 | 164 | 7 | CID000008330 | |
| Drug | chlorine atom | 2.65e-05 | 81 | 164 | 6 | CID005360523 | |
| Drug | 4-vinyl-1-cyclohexene dioxide | 3.33e-05 | 170 | 164 | 8 | ctd:C012606 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.15e-09 | 5 | 160 | 4 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.15e-09 | 5 | 160 | 4 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.15e-09 | 5 | 160 | 4 | DOID:0110197 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 5.73e-07 | 13 | 160 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN USP9X POTEF ACTB RBM26 ARHGEF18 CCDC148 TGFBR3 PPARGC1A KIRREL3 PXDN NUP210 PRKCA | 1.09e-06 | 447 | 160 | 13 | EFO_0000694, MONDO_0100096 |
| Disease | Schizophrenia | GABRB2 RELN FOXP2 MYO9B ACTB SREBF1 PPARGC1A PRODH2 TENM4 EIF2S1 LRP2 MTR PRKCA DGCR8 DNM1 PICK1 PCNT RASD2 | 1.59e-06 | 883 | 160 | 18 | C0036341 |
| Disease | HOMA-B | 1.23e-05 | 55 | 160 | 5 | EFO_0004469 | |
| Disease | Baraitser-Winter syndrome | 2.92e-05 | 2 | 160 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 2.92e-05 | 2 | 160 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 2.92e-05 | 2 | 160 | 2 | C1853623 | |
| Disease | collagen disease (implicated_via_orthology) | 3.32e-05 | 12 | 160 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Nonorganic psychosis | 3.74e-05 | 69 | 160 | 5 | C0349204 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 4.30e-05 | 13 | 160 | 3 | C3661489 | |
| Disease | Centronuclear myopathy | 4.30e-05 | 13 | 160 | 3 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 4.30e-05 | 13 | 160 | 3 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 4.30e-05 | 13 | 160 | 3 | C4551952 | |
| Disease | Congenital Structural Myopathy | 4.30e-05 | 13 | 160 | 3 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 5.45e-05 | 14 | 160 | 3 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 5.45e-05 | 14 | 160 | 3 | C0410207 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 6.79e-05 | 15 | 160 | 3 | C3645536 | |
| Disease | autistic disorder (is_implicated_in) | 7.94e-05 | 42 | 160 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 8.71e-05 | 43 | 160 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:0081361 (implicated_via_orthology) | |
| Disease | Cap Myopathy | 8.73e-05 | 3 | 160 | 2 | C3710589 | |
| Disease | Cerebral Palsy, Spastic Quadriplegic, 1 | 8.73e-05 | 3 | 160 | 2 | C2751938 | |
| Disease | Child Behaviour Checklist assessment | 1.20e-04 | 18 | 160 | 3 | EFO_0005661 | |
| Disease | Congenital Fiber Type Disproportion | 1.20e-04 | 18 | 160 | 3 | C0546264 | |
| Disease | pars triangularis volume measurement | 1.67e-04 | 20 | 160 | 3 | EFO_0010321 | |
| Disease | Down syndrome (is_marker_for) | 2.23e-04 | 22 | 160 | 3 | DOID:14250 (is_marker_for) | |
| Disease | Psychotic Disorders | 2.29e-04 | 101 | 160 | 5 | C0033975 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 2.91e-04 | 24 | 160 | 3 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.42e-04 | 239 | 160 | 7 | EFO_0010934 | |
| Disease | Drug habituation | 4.18e-04 | 115 | 160 | 5 | C0013170 | |
| Disease | Drug abuse | 4.18e-04 | 115 | 160 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.18e-04 | 115 | 160 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.18e-04 | 115 | 160 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.18e-04 | 115 | 160 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.18e-04 | 115 | 160 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.18e-04 | 115 | 160 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.18e-04 | 115 | 160 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.18e-04 | 115 | 160 | 5 | C0029231 | |
| Disease | Congenital myopathy with fiber type disproportion | 4.32e-04 | 6 | 160 | 2 | cv:C0546264 | |
| Disease | dementia | 4.32e-04 | 6 | 160 | 2 | MONDO_0001627 | |
| Disease | Substance abuse problem | 4.35e-04 | 116 | 160 | 5 | C0740858 | |
| Disease | breast carcinoma | CCDC91 RALB ILF3 RASA2 MYO9B SREBF1 ANKRD26 EXT1 GRHL2 GDI2 ADD3 ARHGAP5 DNM3 PCNT DNAH11 | 4.54e-04 | 1019 | 160 | 15 | EFO_0000305 |
| Disease | right ventricular ejection fraction measurement | 5.70e-04 | 30 | 160 | 3 | EFO_0021816 | |
| Disease | Nemaline Myopathy, Childhood Onset | 6.03e-04 | 7 | 160 | 2 | C0546125 | |
| Disease | Uveoretinal Coloboma | 6.03e-04 | 7 | 160 | 2 | C4554007 | |
| Disease | Intellectual Disability | 7.81e-04 | 447 | 160 | 9 | C3714756 | |
| Disease | Nonsyndromic genetic hearing loss | 7.89e-04 | 76 | 160 | 4 | cv:C5680182 | |
| Disease | Myopathies, Nemaline | 8.01e-04 | 8 | 160 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 8.01e-04 | 8 | 160 | 2 | cv:C0206157 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | post-traumatic stress disorder | 8.46e-04 | 202 | 160 | 6 | EFO_0001358 | |
| Disease | molar-incisor hypomineralization | 1.03e-03 | 9 | 160 | 2 | EFO_0005321 | |
| Disease | Congenital ocular coloboma (disorder) | 1.03e-03 | 9 | 160 | 2 | C0009363 | |
| Disease | Liver Cirrhosis, Experimental | TPM3 SYNRG SREBF1 PSTPIP1 ADD3 PRODH2 KANK1 PXDN SULT2A1 SNX7 CDH5 EPB41L2 | 1.10e-03 | 774 | 160 | 12 | C0023893 |
| Disease | thyroxine measurement | 1.10e-03 | 83 | 160 | 4 | EFO_0005130 | |
| Disease | Bipolar Disorder | 1.23e-03 | 477 | 160 | 9 | C0005586 | |
| Disease | Hereditary hearing loss and deafness | 1.23e-03 | 146 | 160 | 5 | cv:C0236038 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Asthma, Occupational | 1.28e-03 | 10 | 160 | 2 | C0264423 | |
| Disease | Congenital neurologic anomalies | 1.28e-03 | 10 | 160 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.28e-03 | 10 | 160 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | lung carcinoma | 1.32e-03 | 482 | 160 | 9 | EFO_0001071 | |
| Disease | cups of coffee per day measurement | 1.33e-03 | 40 | 160 | 3 | EFO_0006782 | |
| Disease | aspartate aminotransferase measurement | DPP6 TRPM7 CDKN2AIP OBSCN PDPK2P SERPINA2 SLC2A2 PPARGC1A IPO9 ABCB11 CBX1 PRKCA MOV10 | 1.35e-03 | 904 | 160 | 13 | EFO_0004736 |
| Disease | Sensory hearing loss | 1.56e-03 | 11 | 160 | 2 | C1691779 | |
| Disease | autism spectrum disorder | 1.65e-03 | 156 | 160 | 5 | EFO_0003756 | |
| Disease | left ventricular systolic function measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0008206 | |
| Disease | age at diagnosis, osteonecrosis | 1.76e-03 | 44 | 160 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | Congenital myopathy (disorder) | 1.86e-03 | 12 | 160 | 2 | C0270960 | |
| Disease | Liver carcinoma | 1.86e-03 | 507 | 160 | 9 | C2239176 | |
| Disease | hearing impairment | 2.03e-03 | 98 | 160 | 4 | C1384666 | |
| Disease | Alzheimer's disease biomarker measurement | 2.26e-03 | 48 | 160 | 3 | EFO_0006514 | |
| Disease | Mammary Carcinoma, Human | 2.35e-03 | 525 | 160 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.35e-03 | 525 | 160 | 9 | C1257931 | |
| Disease | JT interval | 2.40e-03 | 248 | 160 | 6 | EFO_0007885 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.40e-03 | 49 | 160 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms | 2.42e-03 | 527 | 160 | 9 | C1458155 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.55e-03 | 14 | 160 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | unipolar depression, anxiety | 2.55e-03 | 14 | 160 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 2.55e-03 | 14 | 160 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.60e-03 | 105 | 160 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 2.77e-03 | 538 | 160 | 9 | C0678222 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.79e-03 | 107 | 160 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Alzheimer's disease (is_marker_for) | 2.86e-03 | 257 | 160 | 6 | DOID:10652 (is_marker_for) | |
| Disease | serum alanine aminotransferase measurement | TRPM7 BAZ1B ACTG1 SERPINA2 SLC2A2 BPTF TENM4 NUP210 ABCB11 PRKCA MX1 BRWD1 | 2.86e-03 | 869 | 160 | 12 | EFO_0004735 |
| Disease | Streptozotocin Diabetes | 2.88e-03 | 108 | 160 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 2.88e-03 | 108 | 160 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 2.88e-03 | 108 | 160 | 4 | C0002152 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 2.93e-03 | 15 | 160 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | hair morphology measurement | 3.17e-03 | 54 | 160 | 3 | EFO_0007821 | |
| Disease | coffee consumption measurement | 3.21e-03 | 182 | 160 | 5 | EFO_0006781 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 3.34e-03 | 16 | 160 | 2 | DOID:12858 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYKGGRERTEEQKEE | 76 | Q96KV6 | |
| YGKCVIVVKERRQQE | 116 | B9A014 | |
| VYNDRGEIVKTKERR | 651 | O15013 | |
| QKREVVKRQDVLYEL | 441 | Q6ZSZ5 | |
| LIAEQSLKDRERVKY | 446 | Q8NFR7 | |
| QRKVDGIQKAYDELR | 331 | Q8N998 | |
| DEVKRGIYKRTAVIQ | 431 | Q9UBJ2 | |
| VREYREKVETELQGV | 81 | P31947 | |
| LYIAREGKEEIVKVT | 116 | Q86V21 | |
| ELEEYKRTIERKQQG | 561 | Q9UEY8 | |
| AEYSVKIELKRLGVV | 436 | Q96KE9 | |
| GIRESQLKERLEKRY | 1011 | Q9UIG0 | |
| REIVRDIKEKLCYVA | 206 | P60709 | |
| REIVRDIKEKLCYVA | 206 | P63261 | |
| LGKNRTEAEVKRYTE | 656 | Q8N4X5 | |
| VALKIIRNVGKYREA | 331 | P49761 | |
| KRLYQRAREEEKGIE | 201 | Q16854 | |
| EEKLGAKYVERTRLD | 3901 | Q96DT5 | |
| GEKREVERYEKNLVF | 296 | O95342 | |
| RNRIKVTKDGYADIV | 341 | P49753 | |
| ELLRETKRKYESVLQ | 131 | P53365 | |
| DSKRVEQLAREKVYL | 206 | Q9Y592 | |
| DTLYEKIREQLRRKE | 806 | Q9UPS8 | |
| KDRKVLYTGAERDVR | 131 | Q8WYQ5 | |
| KDYEGLKRVLRSLQA | 2931 | Q12830 | |
| ITKSLDREKQARYEI | 211 | P33151 | |
| EIGYLDRTSQKLKRL | 26 | Q8WWH4 | |
| IEGKLERRNIIKDYS | 351 | Q7Z4T9 | |
| YDDEKLKTLGARVTR | 116 | Q8IWA6 | |
| VKLVRGAYLDKERAV | 376 | Q9UF12 | |
| EKYRVLARRVTLDGK | 566 | Q9Y483 | |
| YRKKVVLDGEEVQID | 51 | P11233 | |
| YRKKVVLDGEEVQID | 51 | P11234 | |
| RKYTELQLEAAKRGI | 836 | Q5T8P6 | |
| VYDKNVLQRDLRIGK | 106 | Q15283 | |
| IYVGRAQKKVERQTE | 261 | P11940 | |
| LYIRVVDKVEIGKTV | 981 | Q8TEM1 | |
| YIRDVAKQVKARLRE | 236 | P06132 | |
| ERYGKELVQIARKAG | 51 | O43586 | |
| REIVRDIKEKLCYVA | 906 | A5A3E0 | |
| YVKDRVEKVGQVIRV | 286 | P50395 | |
| KIRYGKSIRGEEIEN | 26 | Q3KP22 | |
| DAEVYELRSRGKEKV | 36 | Q7Z3D4 | |
| KYVDKRLEQLGAQRI | 186 | P16435 | |
| KETYKLQRRETIKGI | 226 | Q9Y287 | |
| EKELRREISYAIKNI | 381 | Q05193 | |
| VVVIRVDKEKGYIDL | 71 | P05198 | |
| GTEKAKLVELYRIVV | 96 | P15018 | |
| KRKYRGSEIEDLVLL | 546 | Q9NXV6 | |
| KKNSLRVEGDNIYVR | 611 | O43491 | |
| EKELRREISYAIKNI | 381 | Q9UQ16 | |
| VKNLTYIRKALEDIR | 281 | Q99645 | |
| IIRKDVDVYSQILRK | 56 | Q9BW27 | |
| IVYGVKTKEIRQRIL | 291 | Q8TCB6 | |
| LREKDQIYEKERTLR | 1646 | Q92817 | |
| DEVEYQKRRSQKITG | 576 | O15409 | |
| KRVSISEGDDKIEYR | 121 | P22087 | |
| KRLRGYDDVTKDINE | 261 | P11168 | |
| IRRYSLGQVSKEERK | 426 | Q14D04 | |
| VEQYERETNRLKKAL | 226 | Q5W0B1 | |
| KEKIYRLEVQLRETT | 466 | Q14678 | |
| VKETVDRLLKGYDIR | 36 | P47870 | |
| RNRYLVISEKLEEIK | 156 | Q9Y546 | |
| TIKYDGTDRRVIAKE | 4256 | P98164 | |
| IIKENKVPYVTRERD | 91 | Q6A1A2 | |
| QEELRGKEDDKIYRG | 141 | O15541 | |
| EKDLRREISYAIKNI | 381 | P50570 | |
| RRQVELLAYKVEQEK | 2561 | O95613 | |
| QEVKGVKRYSAEVRL | 701 | Q6NV74 | |
| KKEEAYELVRRGLRN | 61 | Q9BXJ9 | |
| IYVGRAQKKVERQTE | 261 | Q9H361 | |
| ENDIILYAKIEGRKE | 491 | P78509 | |
| EVGNYKRTVKRIDDG | 21 | Q9BY11 | |
| DRLYRKGVVTEAEVK | 6551 | Q5VST9 | |
| KAIEERRVIYVGKIR | 671 | Q9UBK2 | |
| REIVRDIKEKLCYVA | 906 | Q6S8J3 | |
| VRVKEGREGKLDVYL | 416 | Q3KR16 | |
| TGNIVLRKRLNYEDK | 211 | Q96QU1 | |
| YVEKRTGRKVVDLVK | 186 | P20848 | |
| NVYTEKKEIAILRER | 416 | Q9ULG6 | |
| IIVSKRRFQYEEEVK | 471 | Q9BZJ0 | |
| SRKTIGKVRVDYIII | 281 | Q9NPB8 | |
| KEEGTKRVLLYVRKE | 531 | Q6ISB3 | |
| AAEVLKVQKRRIYDI | 156 | Q01094 | |
| DQVSILRKKYRDIER | 731 | Q16394 | |
| KQYEKERQRLVTGIE | 511 | Q5T9S5 | |
| RTRDELIEYIKEQKR | 391 | Q7Z6B0 | |
| EGTRKREYENELAKV | 1181 | P15924 | |
| GKKSDRRELYVILNQ | 441 | P86791 | |
| ELNEKRRGLKYELIS | 531 | Q12906 | |
| YVVEKVLDRRVVKGK | 21 | P83916 | |
| GKKSDRRELYVILNQ | 441 | P86790 | |
| EETEKIYRGEAVRKG | 511 | Q96GE4 | |
| KGEEERNLYIIGRKR | 761 | Q9NSI6 | |
| EIRALYNVLAKVKRE | 201 | Q5TF58 | |
| KERIRLARQIEKSEY | 726 | Q9GZR7 | |
| GLYRDERLKQKAESL | 326 | Q9H819 | |
| KRLQDIRVKGEEIYS | 876 | Q96P70 | |
| VIGEKIYKDGERIIT | 276 | P13861 | |
| KRGQIIKEASGEVYR | 286 | Q8IZU9 | |
| ARYGSVKEVKIITDR | 61 | Q92904 | |
| VAVKIVKNVGRYREA | 186 | Q9HAZ1 | |
| GKKIESLRAIRYEIS | 181 | P42658 | |
| KATVEYQKEVIRLLR | 2486 | Q02224 | |
| RRKKEYIDGLESRVA | 236 | Q8TEY5 | |
| REIISKGTQEVLKYL | 351 | Q9H9A6 | |
| YIAIRLGKTDIRDKE | 1516 | Q9HC10 | |
| YGVKTKQIREQVLRI | 291 | Q8NH55 | |
| RKGTEVQVDDIKRVY | 416 | Q9Y230 | |
| SKTEDRKEYNIGVLR | 1631 | Q93008 | |
| RRELKEKEYSVLNAV | 2606 | P46939 | |
| NLSKEDDVRQYVVRK | 146 | P62753 | |
| SLRKREGEYSKVLAI | 126 | Q6P1L8 | |
| RIKAKLTQIRRYGEE | 1521 | Q8NF91 | |
| SAREKGERAVKYLEE | 3766 | Q8NF91 | |
| KYLEEGEAERLRKEI | 3776 | Q8NF91 | |
| EVYRVTKRVELGIKA | 1176 | Q9UMZ2 | |
| YNLTRERDELIGKLK | 566 | Q7Z7B0 | |
| TEKRGRIYLKAEVAD | 156 | P17252 | |
| QVEKIRYCITKLDRE | 836 | Q9HCE1 | |
| IRELRKTNYVENLKE | 491 | Q96NG3 | |
| VERKKEIARLCGYDV | 496 | Q7RTZ1 | |
| VVIIRNKYGRLTRDK | 51 | Q9Y227 | |
| ERLKQREEVLRKIYT | 211 | Q8NHV1 | |
| VEERLEYALVKGIEK | 671 | Q99707 | |
| FDKVRRVLKSQEVYE | 311 | O75182 | |
| REIVRDIKEKLCYVA | 906 | P0CG38 | |
| SKEVYGRHQREIVEK | 471 | Q13017 | |
| VDYVVDKAQLLRKGV | 236 | Q06520 | |
| KKGNTLSRDLIDYVR | 106 | Q9Y3C1 | |
| VDRVIKGQKYEKRIE | 266 | Q9BYC2 | |
| KGQKYEKRIERLTIL | 271 | Q9BYC2 | |
| NLIDKISQRIYKEER | 201 | Q9UNH6 | |
| YKEVAELTRLRKQAL | 831 | Q01082 | |
| IEKRYRSSINDKIIE | 331 | P36956 | |
| ELEEYRREVERKQKG | 571 | P35611 | |
| EVDKRELIALKRVGY | 2121 | Q8N3C0 | |
| FEEECRKYRTLVIKG | 291 | Q9Y4C5 | |
| RPVIEKRIQKYSEGE | 201 | Q9Y5K5 | |
| DQRYGKRVIQKALEE | 376 | Q9UBS8 | |
| YVLVSQEKRKREQDA | 456 | Q92618 | |
| GKDREYTDIIRKQVL | 156 | P49427 | |
| QRGVRIYDGEEKIKF | 21 | Q86VN1 | |
| KRRAVEATGEKVLRY | 6 | Q9UBK9 | |
| GGKIEEVKRRQYSLA | 201 | Q6ZVD8 | |
| VRDIQDRSIIKIYRK | 246 | Q9C0H9 | |
| EVKDRIKSNVDGRYL | 191 | P23942 | |
| EIREKLKRLYGSTLN | 1196 | Q92626 | |
| REEIKRLKDYLTVLQ | 416 | Q9UHP3 | |
| YGERAINKVKSVRDE | 446 | Q5JSH3 | |
| YIKAKVLREGQARER | 246 | Q96D21 | |
| LYIAETDEKKINRIR | 1481 | Q6N022 | |
| LYITETDEKKINRIR | 1416 | Q9P273 | |
| ERYGEKGKAIRIEKV | 861 | O43151 | |
| REDVGKVKFDIRYIV | 461 | Q14166 | |
| KELIKVLIQRGYDSD | 1071 | P11388 | |
| QLIGDDVKVERIEYK | 166 | Q9UBQ0 | |
| RKSKLYGAVAEQLRE | 526 | Q63HK3 | |
| KYGAVREVILKELAE | 176 | O96006 | |
| IIRLKKYEKRGELVT | 41 | Q9Y2P4 | |
| KYEEVARKLVILEGE | 161 | P07951 | |
| KRLEELERTAELYKG | 151 | Q9NRD5 | |
| RKYEEVARKLVIIEG | 161 | P06753 | |
| IKEVGDRVNYIKRSL | 1211 | Q96QT4 | |
| ELKIARNIYIKVGED | 176 | Q03167 | |
| RNGKYRLLKISIENE | 21 | Q12792 | |
| QVYRGALQKVREKEL | 536 | P20591 | |
| EIAKDYRVGDKVLRL | 26 | Q9NQX4 | |
| RGAVVEKYLLEKSRL | 311 | Q13459 | |
| IRKYQESDRKSVVGL | 6 | Q9UHF3 |